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Uncoupling protein-1, a mitochondrial inner membrane protein, is the main player in 
non-shivering thermogenesis and is expressed in brown and brown-like adipocytes. 
Uncoupling protein 1-mediated thermogenesis leads to excess energy expenditure 
as the fat energy storage is used for body heat production and thus, is one of the 
most rapidly advancing areas in obesity research. The present PhD project aims to 
identify factors to treat human adipose excess through uncoupling protein-1 
activation. Our systematic analysis identified L-menthol as one of the molecules that 
can activate rodent UCP1 in brown and brown-like adipocytes through transient 
receptor potential melastatin 8 ion channel (TRPM8) stimulation, leading to increase 
rodent metabolism and decrease adiposity. In humans, a single L-menthol skin 
administration increased thermogenesis and metabolic rate but these showed a 
minor increase following oral L-menthol administration. However, 1-month of daily L-
menthol cream application did not increase human metabolism or white adipose 
tissue plasticity and did not affect body composition. Future analysis on the activity of 
proteins involved in metabolism and white adipose tissue plasticity following daily L-
menthol administration and also on human TRPM8 cold-sensitive gating are 
essential to clarify the observed results and thus, to confirm L-menthol as promising 
candidate treatment for human cardio-metabolic diseases. 
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NST = non-shivering thermogenesis  
UCP1 = uncoupling protein 1 
BAT = brown adipose tissue 
WAT = white adipose tissue 
EE = energy expenditure 
M = metabolic rate 
BMR = basal metabolic rate 
RER = respiratory exchange ratio 
HRV = heart rate variability 
S = heat storage 
Tsk = skin temperature 
Tre = rectal temperature 
SkBF = skin blood flow 
RMR = resting metabolic rate 
BMI = body mass index 
BW = body weight 
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Obesity and its related disorders represent a major global health concern. Recent 
studies reported that during the last thirty-five years worldwide mean body mass 
index has been increasing by 0.45 kg/m² per decade, while rates of overweightness 
and obesity are projected to increase in almost all countries (World Health 
Organization 2010; World Health Organization 2010; Finucane et al. 2011). The 
countermeasure often proposed against overweightness and obesity is a reduction of 
energy intake and/or an increase in physical activity (Flouris et al. 2008; Bischoff et 
al. 2012; Carrillo et al. 2013; Golubovic et al. 2013). However, increasing basal 
metabolic rate (BMR) through frequent stimulation of non-shivering thermogenesis 
(NST) is also a viable alternative that can be beneficial (Feldmann et al. 2009; 
Shabalina et al. 2010; Carrillo and Flouris 2011). This is because up to 20% of 
average daily metabolic rate may consist of cold-induced NST (van Marken 
Lichtenbelt and Schrauwen 2011). 
NST which is a heat production process not associated with the muscle 
shivering, takes place in mammal brown adipose tissue (BAT) and human skeletal 
muscle (Wijers et al. 2008; Mattson 2010; Mitchell et al. 2010; van Marken 
Lichtenbelt and Schrauwen 2011). Uncoupling protein 1 (UCP1), a mitochondrial 
inner membrane protein, is the main player in NST process and is expressed in 
mammal brown and brown-like (beige or brite) adipocytes (Mattson 2010; Petrovic et 
al. 2010; Walden et al. 2012). Frequent stimulation of UCP1 results in an increase of 
basal metabolic rate and a reduction of adiposity levels in rodents as the fat energy 
storage is used for body heat production (Inokuma et al. 2006; Yamashita et al. 2008; 
Feldmann et al. 2009; Yoneshiro et al. 2013; Valente et al. 2014). Briefly, the 
expression of UCP1 in brown and brown-like adipocytes provides an alternative 
biochemical pathway compared to the rest of eukaryotic cells which results in the 
production of heat instead of ATP. Normally, the protons that are pumped across the 
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mitochondrial inner membrane due to the oxidation of NADH and FADH2 by the 
electron transport chain generate an electrochemical gradient which is dissipated as 
they enter the mitochondrial matrix through ATP synthase resulting in ATP 
production. However, the activation of UCP1 in brown and brown-like adipocytes 
allows protons to bypass the ATP synthase entry and return to the mitochondrial 
matrix. Through this process, the energy of the electrochemical gradient is dissipated 
as heat (Rousset et al. 2004; Ducharme and Bickel 2008; Mattson 2010). Thus, 
adipose tissue biology pertaining to UCP1-mediated thermogenesis is one of the 
most rapidly advancing areas in obesity research, with an ever-increasing number of 
molecular, physiological, pharmacological and dietary factors implicated in increasing 
metabolism and decreasing adiposity being therefore potential targets for obesity 
management.  
Given the above, the present PhD project aims to identify factors that 
increase human metabolism and treat adipose excess through UCP1 activation.  The 
following three studies are included: 1) a systematic review to analyse all published 
evidence from 2006 to 2013 regarding the molecular pathways linking NST and 
obesity in mammals, focusing on mechanisms involved in BAT development; 2) 
absorption and metabolism of a single L-menthol oral versus skin administration and 
the effects on human thermogenesis and metabolic rate; 3) effect of daily L-menthol 
skin administration on metabolism, body composition and white adipose tissue 
plasticity. 
 
THESIS OBJECTIVES  
 
The thesis objectives are: 
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1) Evaluate the available recent evidence on the molecular pathways linking 
NST and obesity in mammals, focusing on the mechanisms involved in BAT 
development. 
2)  Assess the effects of one of the identified factors on increase human 





The research hypotheses are: 
1)  Both L-menthol oral and skin L-menthol administration would increase 
thermogenesis and metabolic rate in humans.  
2) L-menthol skin administration would be more potent in increasing 
thermogenesis and metabolic rate in humans. 
3) 1-month daily L-menthol cream administration (lower and higher L-menthol 
concentration cream) would increase human metabolism, decrease body 
weight and adiposity.  
4) 1-month daily L-menthol cream administration (lower and higher L-menthol 
concentration cream) would stimulate subcutaneous adipose tissue plasticity 
with UCP1 expression increased in subcutaneous white adipocytes. 
5) The daily administration of the higher L-menthol cream concentration would 
be more potent in increasing human metabolism, decreasing body weight and 
adiposity as well as stimulating subcutaneous adipose tissue plasticity. 
The research null hypotheses are: 
1) Oral or skin L-menthol administration would not increase thermogenesis and 
metabolic rate in humans.  
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2) Skin administration would have a similar effect as oral administration on 
thermogenesis and metabolic rate in humans. 
3) 1-month daily L-menthol cream administration (lower or higher L-menthol 
concentration cream) would not increase human metabolism, decrease body 
weight and adiposity.  
4) 1-month daily L-menthol cream administration would not stimulate 
subcutaneous adipose tissue plasticity with UCP1 expression increased in 
subcutaneous white adipocytes. 
5) The daily administration of the higher L-menthol cream concentration would 
have a similar effect on human metabolism, body weight and subcutaneous 
adipose tissue plasticity. 
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An increase in energy intake and/or a decrease in energy expenditure lead to fat 
storage, causing overweight and obesity phenotypes. The objective of this review 
was to analyse, for the first time using a systematic approach, all published evidence 
from the past eight years regarding the molecular pathways linking non-shivering 
thermogenesis and obesity in mammals, focusing on mechanisms involved in brown 
adipose tissue development. Two major databases were scanned from 2006 to 2013 
using “brown adipose tissue” AND “uncoupling protein-1” AND “mammalian 
thermoregulation” AND “obesity” as key words. A total of 61 articles were retrieved 
using the search criteria. The available research used knockout methodologies, 
various substances, molecules and agonist treatments, or different temperature and 
diet conditions, to assess the molecular pathways linking non-shivering 
thermogenesis and obesity. By integrating the results of the evaluated animal and 
human studies, our analysis identified specific molecules that enhance non-shivering 
thermogenesis and metabolism by: (i) stimulating “brite” (brown-like) cell 
development in white adipose tissue; (ii) increasing uncoupling protein-1 expression 
in brite adipocytes; and (iii) augmenting brown and/or brite adipose tissue mass. The 
latter can be also increased through low temperature, hibernation and/or molecules 
involved in brown adipocyte differentiation. Cold stimuli and/or certain molecules 
activate uncoupling protein-1 in the existing brown adipocytes, thus increasing total 
energy expenditure by a magnitude proportional to the number of available brown 
adipocytes. Future research should address the interplay between body mass, brown 
adipose tissue mass, as well as the main molecules involved in brite cell 
development. 
Key words: brite cells, metabolism, energy expenditure, white adipose tissue, 
retinaldehyde dehydrogenase 1, tri-iodothyronine, uncoupling protein-1. 
Institutional Repository - Library & Information Centre - University of Thessaly





Since 1980, worldwide mean body mass index has been increasing by 0.45 kg/m² 
per decade (Finucane et al. 2011). By the end of 2010, around 43 million children 
under the age of five were overweight, while rates of overweightness and obesity are 
projected to increase in almost all countries, leading to 1.5 billion overweight 
individuals by 2015 (World Health Organization 2010). The countermeasure often 
proposed against overweightness and obesity is a reduction of energy intake 
(Golubovic et al. 2013) and/or an increase in physical activity (Flouris et al. 2008; 
Bischoff et al. 2012; Carrillo et al. 2013). However, increasing basal metabolic rate 
(BMR) through frequent stimulation of non-shivering thermogenesis (NST) – via 
changes in the thyroid hormones – is also a viable alternative that can be beneficial 
(Koutedakis et al. 2005; Feldmann et al. 2009; Shabalina et al. 2010; Carrillo and 
Flouris 2011). This is because human data summarized in a recent review showed 
that up to 20% of average daily metabolic rate may consist of cold-induced NST (van 
Marken Lichtenbelt and Schrauwen 2011). In rodents, NST takes place exclusively in 
brown adipose tissue (BAT) by uncoupling protein-1 (UCP1) (Mattson 2010), a 
mitochondrial inner membrane protein, while in humans NST can also occur in 
skeletal muscle (Wijers et al. 2008; Mitchell et al. 2010; van Marken Lichtenbelt and 
Schrauwen 2011). The prevailing hypothesis to date is that the function of BAT in 
mammals is to maintain body temperature during exposure to cold which, as a 
consequence, leads to excess energy expenditure (EE) (Kozak 2010). Indeed, 
frequent stimulation of NST irrevocably increases BMR, resulting in decreased body 
mass and stored fat (Feldmann et al. 2009; Shabalina et al. 2010). 
 Adipose tissue biology pertaining to UCP1-mediated thermogenesis is one of 
the most rapidly advancing areas in obesity research, with an ever-increasing 
number of molecular, physiological, pharmacological and dietary factors being 
implicated in the transdifferentiation of white adipocytes to “brite” (i.e. brown-like) 
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adipocytes and potential targets for obesity management. In rodents, brite cells in 
white adipose tissue express UCP1 and may play an important role in NST and 
metabolism when UCP1 is activated through pathways similar to those of brown 
adipocytes. Nevertheless, brite cells possess a different gene expression pattern 
(e.g. transcription factors) than classic brown adipocytes (Petrovic et al. 2010; 
Walden et al. 2012). 
  BMR is reduced with ageing in humans (Carrillo and Flouris 2011), while an 
ageing effect on NST has been also observed in rodents (Feldmann et al. 2009; 
Shabalina et al. 2010), leading to overweightness or obesity. Moreover, a recent 
human study reported that obese individuals demonstrate low BAT activity and EE in 
response to cold compared with lean controls, suggesting that BAT is either reduced 
or absent in obese individuals (Vijgen et al. 2011). Therefore, it is crucial to intensify 
research efforts aimed at the prevention of BAT loss and/or BAT regeneration to treat 
human adipose excess. 
The importance of systematic analyses is based on reducing the likelihood of 
bias on the effects of certain phenomena across a wide range of settings and 
empirical methods (Wieseler and McGauran 2010). However, recent research 
findings concerning BAT biology and its role in obesity have not yet been reviewed 
using a systematic methodology. Thus, the purpose of this review is to summarise 
critically– for the first time using a systematic approach – all the recent evidence on 
the molecular pathways linking NST and obesity in mammals, focusing on the 




This systematic review was performed according to published guidelines (Wieseler 
and McGauran 2010). The databases PubMed and Scopus were searched for 
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articles published from the beginning of 2006 to the end of October 2013, using the 
key words “brown adipose tissue” AND “uncoupling protein-1” AND “mammalian 
thermoregulation” AND “obesity”. We used 2006 as a start year for this systematic 
search because, in that year, UCP1 was established as the only mediator of NST in 
mammalian BAT (Barger et al. 2006). The limitation “research articles” was applied to 
the search parameters in order to exclude reviews and conference proceedings. Only 
English-language literature was considered eligible. Titles and abstracts were 
screened independently by two reviewers (A.V. and A.D.F.) to identify relevant 
articles. 
Due to the methodology outlined above, our searching and selection 
procedure eliminated bias since the inclusion (or not) of a study was based on 
content (i.e. investigating molecular pathways linking NST and obesity with a focus 
on the mechanisms involved in mammalian BAT development), and not on quality, 
journal, or other factors. A total of 56 articles were retrieved during the search and all 
were identified as relevant (Fig. 1).  
 
Figure 1. Systematic selection process used to identify relevant studies within the adopted 
criteria. 
Five additional articles were included manually. These five articles met all the set 
criteria but were excluded erroneously from the 56 articles when the search limits 
were applied. Therefore, 61 articles meeting all the established criteria were 
considered for subsequent analysis. To enable a systematic synthesis of the 
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presented evidence, the articles were separated into two categories based on 
research methodology: “knockout studies” in which gene-function analysis was 
performed using knockout animals lacking the gene under study (Table 1), and “other 
studies” in which the analysis was carried out using various substances, 
molecules/agonist treatments, as well as different temperature and diet conditions 
(Table 2). 
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Table 1. The “Knockout studies” articles identified by our search criteria and their main results. 
Group Article Main results 
UCP1-KO 
Yamashita et al. (2008) FABP3 affects free fatty acid flux and ↑UCP1 thermogenesis. 
Feldmann et al. (2009) UCP1 activity affects obesity development in mice and humans. 
Inokuma et al. (2006) Anti-obesity effect of β3-adrenergic stimulation is largely attributable to UCP1 in BAT.  
Oelkrug et al. (2011) Functional BAT is essential for rapid arousal from torpor. 
Shabalina et al. (2010) ↑shivering muscle and ↓heat loss induces cold adaptations in UCP1-KO mice. 
Anunciado-Koza et al. (2011) SLC25A25 induces alternative thermogenesis. 
Meyer et al. (2010) ↓heat loss by ↑vasoconstriction and ↓thermal conductance in UCP1-KO mice. 
Adjeitey et al. (2013) UCP1 expression in muscles ↑ EE, ↓ body mass, and ↓ reactive oxygen species production. 
Brain 
Streijger et al. (2009) Inefficient neuronal transmission induces dysfunction in NST. 
Chao et al. (2011) Deficiency of NPY induces ↑both WAT lipogenesis and BAT thermogenesis. 







Korach-Andréa et al. (2011) Deficiency of LXRα and LXRβ induces ↑ EE, ↑ UCP1 expression and ↓ body mass loss. 
Vila-Bedmar et al. (2012) GRK2 hemizygous (+/-) induces ↑ NST, ↑ EE and ↓ body mass. 
Pelletier et al. (2008) Chronic muscle shivering in mice with dysfunctional NST. 
Hudson-Davies et al. (2009) Deficiency of RIP140 ↓ metabolism and ↓ thermoregulatory adaptations. 
Gray et al. (2006) PPAR-γ is required for full activation and recruitment of brown adipocytes. 
Giralt et al. (2011) Sirt3 is essential for the differentiation of fully thermogenic-competent brown adipocytes. 
Bordicchia et al. (2012) Cardiac NPs induce ↑ BAT thermogenesis, ↑ PGC-1α and ↑ UCP1 and ↓ WAT mass via p38 
MAPK. 
Tseng et al. (2008) BMP-7 induces brown adipocyte differentiation and NST. 
Jimenez-Preitner et al. (2011) Plac8 is required for BAT differentiation and thermogenic capacity. 
Czyzyk et al. (2012) δ-opioid receptor deficiency induces ↑ UCP1 and ↓ adiposity. 
Satyanarayana et al. (2012) Id1 deficiency induces ↑ UCP1, ↑ EE, and ↑ fatty acid oxidation. 
Lin et al. (2011) GHS-R ablation induces ↑ insulin sensitivity, ↑ EE, ↑ resting metabolic rate and ↑ UCP1 during 
ageing. 
Ma et al. (2011) GHS-R regulates BAT NST, adiposity, metabolism and energy homeostasis during ageing. 
Mano-Otagiri et al. (2010) GHS-R/ghrelin induces ↓ EE and ↑ EI by suppressing the SNS innervating BAT. 
Kiefer et al. (2012) Rald induces ↑ transcription of brown fat markers in WAT. 
Bauwens et al. (2011) α1-AMPK does not play a key role in NST and body mass. 
↑= increase; ↓= decrease; α1-AMPK = α1-AMP-activated protein kinase; BAT = brown adipose tissue; BMP-7 = bone morphogenetic protein 7; EE = energy expenditure; EI = energy 
intake; FABP3 = fatty acid-binding protein 3; GHS-R = growth hormone secretagogue receptor; GRK2 = G-protein-coupled receptor kinase 2; Id1 = inhibitor of DNA binding 1; KO = 
knockout; LXR = liver-X receptor; NPs = natriuretic peptides; NPY = hypothalamic neuropeptide Y; NST = non-shivering thermogenesis; p38 MAPK = p38 mitogen-activated protein 
kinase; PGC-1α = peroxisome proliferator-activated receptor gamma co-activator 1-α; Plac8 = placenta-specific 8; POMC = proopiomelanocortin; PPAR-γ = peroxisome proliferator-
activated receptor γ; PTP1B = protein tyrosine phosphatase 1B; Rald = retinaldehyde dehydrogenase 1; RIP140 = receptor interacting protein 140; Sirt3 = silent mating type 
information regulation 2, homolog 3; SLC25A25 = solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25; SNS = sympathetic nervous system; UCP1 = 
uncoupling protein-1; WAT = white adipose tissue. 
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Table 2. The “other studies” identified by our search criteria and their main results. 
Group Article Main results 
Molecule 
treatment 
Lehr et al. (2009) T3 in brown adipocyte medium induces differentiation of WAT stroma vascular cells in 
brown adipocytes-like cells. 
Bartolomucci et al. (2006) TLQP-21 ↑EE and blocks the early phase of high-fat-diet-induced obesity. 
Kim et al. (2006) PE extract ↑BAT thermogenesis and WAT fatty acid oxidation. 
Matsen et al. (2013) Thyroid hormone β-selective agonist GC-1 induces ↑ UCP1, ↑EE, and ↓ adiposity. 
Ma et al. (2012) L-menthol induces ↑ Tc, ↑ UCP1, and ↓ body mass. 
Romero del Mar et al. (2009) OE maintains thermogenic potential. 
Wargent et al. (2013) ZAG induces no effect on UCP1 expression and NST activity. 
Moriya et al. (2006) QRFP43 ↑feeding, ↓EE, and induces obesity. 
Sex and 
polymorphisms 
Rodriguez-Cuenca et al. 
(2007a) 
Variation of sex steroid receptor expression in BAT of male, female, pregnant and lactating 
females. 
Rodriguez-Cuenca et al. 
(2007b) 
Sex hormones affect mitochondrial transcription factors and mitochondriogenesis. 
Shore et al. (2012) CpG methylation in the UCP1 promoter has no role in UCP1 expression. 
Rose et al. (2011) UCP1 transcription is ↑ by progesterone and retinoic acid but ↓ by 17-β estradiol. 
Nikolic et al. (2011) Sex-difference effect of PKG-I activation on BAT thermogenesis and WAT lipolysis. 
Temperature 
Wells et al. (2012) Opa3 gene mutation indices ↓ NST and ↑ lipid storage in BAT. 
Oelkrug et al. (2013) Original function of BAT in defending mammal high body temperature for migration to cold. 
Cypess et al. (2013) Higher UCP1 expression in longus colli and carotid sheath than superficial BAT depots. 
van der Lans et al. (2013) Cold acclimation induces ↑ BAT activity and ↑ NST but no effect on brite development. 
Yoneshiro et al. (2013) Cold exposure induces ↑EE, ↑ BAT activity, and ↓ body fat mass. 
Li et al. (2013) Cold exposure induces ↑ Bmal1 which is involved in lipid catabolism. 
Chappuis et al. (2013) Cold exposure induces ↑ Per2 which is a co-activator of UCP1 transcription factors. 
Barger et al. (2006) UCP1 is the only mediator of NST in BAT. 
Liu et al. (2009)  Low temperature ↑NST, ↑RMR and ↑total respiratory capacity of BAT. 
Zhang et al. (2009) Cold exposure ↑EE, ↑thermogenic capacity, and ↑EI. 
Zhang et al. (2012) Cold exposure induces ↑ UCP1, ↑body mass, and ↓ leptin. 
Kitao & Hashimoto (2012) Hibernation induces ↑ BAT thermogenesis at low temperature. 




Xiao et al. (2007) Early postnatal over-nutrition induces adverse BAT impact reducing NST in adulthood. 
Zhao & Wang (2009) Changes in nutritional fibre content impact BAT activity, basal metabolic rate, and NST. 
Primeaux et al. (2007) Spinal cord injury induces ↓ body mass, ↓ WAT mass, ↓ UCP1 mRNA and ↑ caloric intake. 
Zhang et al. (2008) Lactating voles ↑ caloric intake, ↑resting metabolic rate, ↓ UCP1 and ↓ body fat mass. 
Leitner & Bartness (2009) MSG ↓BAT NST and induces obesity. 
Cheng et al. (2010) Leucine deprivation induces ↑ EE, ↑ UCP1, ↓ EI, ↓ body mass. 
Du et al. (2012) Isoleucine or valine deprivation induces ↑ EE, ↑ UCP1, ↓ EI, ↓ body mass. 
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Noatsch et al. (2011) ↑ proteins or leucine in diet have no effect on energy homeostasis and UCP1 expression. 
↑= increase; ↓= decrease; BAT = brown adipose tissue; Bmal1 = brain and muscle arnt-l ke 1; CpG = cytosine–phosphate–guanine; EE = energy expenditure; EI = energy intake; 
GC-1 = 2-[4-[(4-hydroxy-3-propan-2-ylphenyl)methyl]-3,5-dimethylphenoxy]acetic acid; MSG = monosodium glutamate; NST = non-shivering thermogenesis; OE = oleoyl-oestrone; 
Opa3 = optic atrophy 3; PE = Pinellia ternata; Per2 = period2; PKG-I = cyclic guanosine monophosphate-dependent protein kinase I; QRFP43 = pyroglutamylated arginine-
phenylalanine-amide peptide; RMR = resting metabolic rate;T3 = tri-iodothyronine; Tc = core temperature; TLQP-21 = VGF-derived peptide; UCP1 = uncoupling protein 1; WAT = 
white adipose tissue; ZAG = zinc-α2-glycoprotein. 
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(1) Knockout studies 
The analysed studies adopting knockout (KO) gene analysis targeted: (a) UCP1, (b) 
molecules of the nervous system, or (c) receptors, enzymes, and transcription factors 
to analyse their impact on NST heat production and obesity. Thus, the “knockout 
studies” were separated into “UCP1-KO”, “Brain”, and “Receptors, enzymes, and 
transcription factors” groups, respectively (Table 1). 
 
(a) UCP1-KO group 
Fatty acid-binding protein 3 is essential for accelerating fatty acid flux into the tissue 
from the bloodstream and for stimulating UCP1 activity for NST in rat BAT 
(Yamashita et al. 2008). UCP1 activity prevents the development of obesity and is 
the only protein that can mediate diet-induced thermogenesis in mouse BAT 
(Feldmann et al. 2009). Specifically, β3-adrenergic stimulation induces BAT NST 
which is fully UCP1-dependent (Inokuma et al. 2006). UCP2 and UCP3 are not 
involved in this process but they play roles in the regulation of cellular energy levels 
and/or oxidation of fatty acids (Inokuma et al. 2006). Therefore, given that UCP1 is 
the only player in NST heat production, its ablation becomes obesogenic in mice fed 
with both high-fat and normal diets due to an inability to stimulate diet-induced 
thermogenesis (Feldmann et al. 2009). The UCP1-KO mice also demonstrate slow 
arousal from torpor because re-warming is less effective and requires additional 
energy (Oelkrug et al. 2011). Despite their dysfunctional NST, UCP1-KO mice are 
cold tolerant probably due to: (i) persistent muscle shivering (Shabalina et al. 2010); 
(ii) up-regulation of ATP-Mg2+/Pi inner mitochondrial membrane solute transporter 
gene in skeletal muscle [which could be a candidate for shivering thermogenesis 
(Anunciado-Koza et al. 2011)]; and/or (iii) reduction of heat loss through adrenergic 
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vasoconstriction (Meyer et al. 2010). On the other hand, ectopic UCP1 expression in 
skeletal muscles results in reduced adiposity and augmented EE in mice (Adjeitey et 
al. 2013). Moreover, the activity of UCP1 in muscle mitigates the production of 
reactive oxygen species in the mitochondria but not in BAT (Adjeitey et al. 2013). 
 
(b) Brain group 
It is well known that the hypothalamus links the nervous system to endocrine 
secretion via the pituitary and that both the hypothalamus and the pituitary express 
factors involved in NST and the regulation of temperature homeostasis in mammals. 
Specifically, cytosolic brain-type creatine kinase deficiency in mice inhibits neuronal 
communication between different hypothalamic circuits involved in NST (Streijger et 
al. 2009). Moreover, dorsomedial hypothalamic neuropeptide Y knockdown in rats 
increases EE and the thermogenic response to cold, and stimulates brown adipocyte 
formation in inguinal white adipose tissue (WAT) (Chao et al. 2011). Other central 
circuits, including the pro-opiomelanocortin neurons that are expressed in the 
pituitary, also regulate energy balance (De Jonghe et al. 2011). Down-regulation of 
pro-opiomelanocortin-protein tyrosine phosphatase 1B, a negative regulator of leptin 
signalling, reduces food intake and body mass in mice and increases their core 
temperature. Furthermore, pro-opiomelanocortin-protein tyrosine phosphatase 1B 
knockout mice show an increase in BAT mass, UCP1 mRNA in BAT, and serum tri-
iodothyronine (T3) and type II iodothyronine deiodinase in response to cold exposure 
despite stable core temperature, food intake, and body mass (De Jonghe et al. 
2011). These results highlight the negative effect of the expression of dorsomedial 
hypothalamic neuropeptide Y and pro-opiomelanocortin-protein tyrosine phosphatase 
1B on body mass regulation via food intake, adiposity, NST, and EE (Chao et al. 
2011; De Jonghe et al. 2011). 
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(c) Receptors, enzymes, and transcription factors group 
The brain plays an important role in metabolism and thermoregulation, yet the 
function of the heart in these pathways also appears to be important. This is due to 
the release of natriuretic peptides from myocardiocytes which can regulate UCP1 
expression promoting the binding of its transcription factors (Bordicchia et al. 2012). 
Indeed, nuclear receptors (described in detail below) play an important role in the 
control of metabolism and thermoregulation, regulating the expression of specific 
genes involved in both mechanisms. The activity of these nuclear receptors is 
mediated by a variety of cofactors and enzymes (also described in detail below) 
whose activity, in turn, depends on specific G-protein-coupled receptors. To evaluate 
effectively the gene function of these receptors, enzymes and transcription factors on 
NST and metabolism, the relevant studies were separated into: positive-effect genes 
(the activation of which promotes NST and EE) and negative or null-effect genes (the 
activation of which decreases or does not affect BAT activity and metabolism, 
respectively). 
 
(i) Positive-effect genes 
Liver-X receptors α and β play key roles in both NST and metabolism in mice, 
controlling EE and body mass loss through UCP1 expression in BAT (Korach-Andréa 
et al. 2011). Other receptors directly involved in the control of EE and body mass 
balance include the G-protein-coupled receptor kinase 2 (Vila-Bedmar et al. 2012), 
the thyroid hormone receptor (Pelletier et al. 2008), and the receptor interacting 
protein 140 (Hudson-Davies et al. 2009). G-protein-coupled receptor kinase 2 
hemizygous (+/-) adult mice exhibit increased EE, BAT activity, white and brown fat 
lipid catabolism as well as core temperature after a cold exposure compared with 
wild-type animals (Vila-Bedmar et al. 2012). On the other hand, studies using KO 
mice for thyroid hormone receptor or receptor interacting protein 140 report a 
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significant reduction in BAT mass associated with poor NST, as well as disturbed 
BAT metabolic gene expression (Hudson-Davies et al. 2009). These results indicate 
that the activation of these receptors results in a positive effect on NST and 
metabolism.  
Transcription factors such as peroxisome proliferator-activated receptor γ 
(PPAR-γ) (Gray et al. 2006) as well as molecules including silent mating type 
information regulation 2, homolog 3 (Sirt3; (Giralt et al. 2011), cardiac natriuretic 
peptides (Bordicchia et al. 2012), bone morphogenetic protein 7 (Tseng et al. 2008) 
and placenta-specific gene 8 protein (Jimenez-Preitner et al. 2011) are involved in 
mouse NST playing key roles in both UCP1 activation and brown adipocyte 
differentiation. Specifically, the transcription factor peroxisome proliferator-activated 
receptor γ co-factor 1α (PGC-1α) is unable to activate the brown adipocyte 
differentiation and the full programme of thermogenic genes, such as UCP1 and type 
2 iodothyronine deiodinase expression, in mice lacking Sirt3 (Giralt et al. 2011). 
Moreover, cardiac natriuretic peptides promote brite cell development (and, thus, 
brite mass) and UCP1 expression in both natriuretic peptide receptor C-null mice and 
in vitro in human white adipocytes through the activation of natriuretic peptide 
receptor A (Bordicchia et al. 2012). 
 
(ii) Negative- or null-effect genes 
Despite the aforementioned effect of specific receptors and transcription factors on 
increasing metabolism and NST, the expression of a group of G-protein-coupled 
receptors, δ-opioid receptors (Czyzyk et al. 2012), as well as inhibitor of DNA-binding 
protein 1 (Satyanarayana et al. 2012), attenuates the activity of UCP1 in mice. 
Indeed, δ-opioid receptor (Czyzyk et al. 2012) or inhibitor of DNA-binding protein 1 
(Satyanarayana et al. 2012) deficient mice demonstrate increased NST and EE as 
well as reduced body mass. Similarly, the ablation of growth hormone secretagogue 
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receptor increases thermogenic capacity and EE in both mice and rats (Mano-Otagiri 
et al. 2010; Lin et al. 2011; Ma et al. 2011). The absence of this receptor under both 
standard and high-fat diets leads to a lean mouse phenotype as well as increased 
EE, BMR, BAT mass and UCP1 gene expression (Mano-Otagiri et al. 2010; Lin et al. 
2011; Ma et al. 2011). Lack of this receptor also leads to increased insulin sensitivity 
and resistance to the effect of ghrelin on BAT especially in older mice (Mano-Otagiri 
et al. 2010; Lin et al. 2011; Ma et al. 2011). 
Aldehyde dehydrogenase 1 family member A1 – expressed more in WAT 
than BAT – irreversibly converts retinaldehyde dehydrogenase 1 (Rald) to retinoic 
acid resulting in a lower WAT functional plasticity (Kiefer et al. 2012). Indeed, in 
aldehyde dehydrogenase 1 family member A1 deficient mice as well as human white 
adipocytes, Rald was not converted into retinoic acid and, thus, it could promote 
transcription of BAT markers in WAT (including UCP1, PPAR-γ, PGC-1α, PR 
(positive regulatory domain 1 binding factor 1 and retinoblastoma protein-interacting 
zinc-finger protein) domain containing 16 (PRDM16), and fatty acid-binding protein 3) 
(Kiefer et al. 2012). This finding demonstrates the key role of Rald in human brite cell 
development. In contrast to all aforementioned positive- and negative-effect genes, 
α1-AMP-activated protein kinase is a metabolic regulator but does not play a role in 
mouse NST and body mass regulation (Bauwens et al. 2011). 
 
(2) Other studies 
To synthesise the available evidence systematically and highlight the critical 
advances of the evaluated studies, the papers included in the ‘other studies’ category 
were separated into four groups: “Molecule treatment”, “Sex and polymorphisms”, 
“Temperature”, and “Diet and reproductive state” in which the effect molecules, sex, 
UCP1 gene polymorphisms, temperature, litter size and diet were analysed, 
respectively, in terms of metabolism and NST (Table 2). 
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(a) Molecule treatment group 
Circulating hormones such as insulin and T3 as well as β3-adrenoceptor agonist CL 
316243 influence NST activity and stimulate brite cell development in WAT (Lehr et 
al. 2009). Such effects, however, are not exerted by circulating oleoyl-oestrone 
(Romero del Mar et al. 2009) and by the β3-adrenoceptor agonist zinc-α2-glycoprotein 
(Wargent et al. 2013). Mouse WAT stroma vascular cells that are cultured in brown 
adipocyte medium containing T3 and β3-adrenoceptor agonist CL 316243 undergo 
brite cell transformation. However, natural substances such as L-menthol in mice (Ma 
et al. 2012) and Pinellia ternata extract in rats (Kim et al. 2006), as well as the 
administration of the thyroid hormone β-selective agonist 2-[4-[(4-hydroxy-3-propan-
2-ylphenyl)methyl]-3,5-dimethylphenoxy]acetic acid (GC-1) in diabetic rats (Matsen et 
al. 2013) increase NST and EE and reduce adiposity, but are not involved in brite cell 
development. Moreover, treatments with specific neuropeptides lead to similar results 
on NST and EE. Indeed, the VGF-derived peptide TLQP-21 increases NST and EE, 
limiting mass gain in rats (Bartolomucci et al. 2006). By contrast, a different 
neuropeptide, pyroglutamylated arginine-phenylalanine-amide peptide (QRFP43), 
reduces mouse BAT-induced NST and results in obesity phenotype development 
(Moriya et al. 2006).  
 
(b) Sex and polymorphisms group 
The different gene expression of steroid receptors (i.e. oestrogen receptor α and 
androgen receptor) in BAT of male and female rats explains sex hormone effects on 
BAT physiology (Rodriguez-Cuenca et al. 2007a). Progesterone activates 
mitochondrial biogenesis by modifying the mRNA expression of several mitochondrial 
transcription factors. For instance, when combined with norepinephrine, 
progesterone increases the mRNA levels of PPAR-γ, but testosterone and 17β-
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estradiol down-regulate its expression (Rodriguez-Cuenca et al. 2007b). Therefore, 
these sex hormones are responsible, at least in part, for the differences in 
mitochondrial biogenesis between the sexes (Rodriguez-Cuenca et al. 2007b). 
Additional human evidence shows that methylation of the cytosine–phosphate–
guanine (CpG) islands in the promoter region of UCP1 does not play a role in UCP1 
protein expression (Shore et al. 2012), but haplotypic variation in the 5'-enhancer 
region of this gene affects NST and metabolism by altering UCP1 protein levels 
(Rose et al. 2011). When this variation is present, 17-βestradiol and progesterone 
produce opposing effects on UCP1 transcription (Rose et al. 2011). Specifically, 
UCP1 transcription activity is increased by progesterone and retinoic acid and 
decreased by 17-βestradiol in the presence of polymorphisms A-3826-G and, 
primarily, C-3737-A in the UCP1 gene sequence (Rose et al. 2011). On the other 
hand, overexpression of cyclic guanosine monophosphate-dependent protein kinase 
I protects female but not male mice against diet-induced obesity by stimulating 
lipolysis in WAT as well as NST in BAT (Nikolic et al. 2011). 
 
(c) Temperature group 
The recent identification of active BAT in protoendothermic mammals (Oelkrug et al. 
2013) supports the prevailing hypothesis that BAT evolved to defend body 
temperature for migration to cold environments. This hypothesis is also supported by 
the recent discovery of higher UCP1 expression in the human longus colli and carotid 
sheath compared to superficial BAT depots. Indeed, the anatomical localisation of 
these depots, which are adjacent to the sympathetic chain and the carotid arteries, 
permits a rapid response to cold stimuli as well as effective heating of the cerebral 
vasculature (Cypess et al. 2013). The recent finding that cold acclimation leads to 
increased EE and BAT activity in humans – without an effect on brite cell 
development in abdominal subcutaneous WAT (van der Lans et al. 2013; Yoneshiro 
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et al. 2013) – further supports the involvement of BAT in body temperature 
regulation. Indeed, cold exposure in mice stimulates NST and induces the expression 
of clock genes, such as brain and muscle arnt-like 1 (Li et al. 2013) and period2 
(Chappuis et al. 2013), that are involved in lipid catabolism and co-activation of 
UCP1 transcription factors leading to increased EE. Despite these findings 
demonstrating a link between BAT and EE, it is important to mention that the 
presence of the mitochondrial regulator function optic atrophy 3 gene mutation leads 
to an increase of lipid storage in mouse BAT without NST activation (Wells et al. 
2012).  
Different lines of evidence suggest that low temperature increases EE, BMR 
and NST in BAT in non-acclimated Brandt’s voles (Lasiopodomys brandtii) (Liu et al. 
2009; Zhang et al. 2009) as well as in tree shrew (Tupaia belangeri) (Zhang et al. 
2012). Interestingly, the effect of cold also has been confirmed in cold-acclimated 
mammals. For instance, prolonged cold exposure of Arctic ground squirrels 
(Urocitellus parryii) generates significant increases in UCP1 mRNA and protein levels 
in BAT (Barger et al. 2006). The same study demonstrated that this cold-induced 
NST is not produced by up-regulation of UCP3 in the muscle. A study on Syrian 
hamsters (Mesocricetus auratus) showed that the ability of cold exposure to induce 
BAT thermogenesis and reduce body mass is stronger in hibernating animals due to 
their greater BAT mass compared to cold- or warm-acclimated animals (Kitao and 
Hashimoto 2012). On the other hand, the effect of cold on body mass loss appears to 
be linked with photoperiod. Specifically, the combined effect of cold and short 
photoperiod (typically occurring in the winter and potentially serving as a seasonal 
cue for the acclimation of energy balance) leads to reduced body mass in 
Maximowiczi’s voles (Microtus maximowiczii) (Chen et al. 2012). 
 
(d) Diet and reproductive state group 
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It is well known that nutrition is considered an important aspect in both metabolism 
and NST playing a key role in obesity and energy balance. In this light, while BAT 
serves to maintain body temperature during exposure to cold, leading to excess EE 
(Kozak 2010), research has shown that BAT thermogenesis can be also influenced 
by dietary factors. Specifically, early postnatal over-feeding in rats leads to 
sympathetic nervous system-mediated permanent changes in BAT thermogenesis 
resulting in reduced NST rates during adulthood (Xiao et al. 2007). However, this 
effect on BAT activity is dependent on nutritional fibre content. Indeed, high-fibre diet 
acclimation in adult Mongolian gerbils (Meriones unguiculatus) decreases BMR and 
NST, but these changes are reversed after restoration to a low-fibre diet (Zhao and 
Wang 2009). 
Adaptation to diet of different fibre content occurs mainly via phenotypic 
plasticity in digestive tract morphology which counteracts changes in body mass 
(Zhao and Wang 2009). Another example of organ adaptation involves high thoracic 
spinal cord injury which triggers a prolonged post-injury loss of body mass and a 
reduction in WAT mass in rats (Primeaux et al. 2007). Interestingly, these changes 
occur despite a decrease in BAT UCP1 gene expression and a higher cumulative 
caloric intake (Primeaux et al. 2007). Therefore, this phenotype is not due to 
hypophagia or an increase in sympathetic nervous system-induced thermogenesis, 
but is caused by permanent changes in gastrointestinal transit and absorption, as 
well as whole-body homeostatic mechanisms (Primeaux et al. 2007). This is also 
confirmed in lactating Brandt’s voles that show a reduction in body fat mass and 
UCP1 content despite an increase in energy intake compared to non-reproductive 
animals. The fact that NST was not augmented during lactation despite a rise in BMR 
may be an energy-conservation strategy for milk production (Zhang et al. 2008). 
Other dietary factors such as the inclusion of food additives and/or the 
removal of specific branched-chain amino acids can also influence NST and 
metabolism. Siberian hamsters (Phodopus sungorus) treated with monosodium 
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glutamate (a molecule used as a food additive) showed a reduction in BAT activity 
associated with obesity phenotype development (Leitner and Bartness 2009). This 
effect on NST and metabolism can also result from feeding animals diets rich in 
leucine (Cheng et al. 2010), valine and isoleucine (Du et al. 2012). Mice fed with 
leucine or valine or an isoleucine deprivation diet show an increase in EE, expression 
of β-oxidation genes, and lipolysis (Cheng et al. 2010; Du et al. 2012). In addition, 
lipogenic gene expression and fatty acid synthesis in WAT are diminished, together 
with a reduction in food intake primarily due to isoleucine and valine. These findings 
together with a higher UCP1 activity in BAT – despite a reduction in BAT mass – 
could explain the WAT loss observed in these isoleucine- or valine-deprived mice 
compared to controls (Cheng et al. 2010; Du et al. 2012). Finally, exposure to high-
protein-content diets or leucine supplementation does not affect energy homeostasis 




The objective of this paper was to evaluate critically, using a systematic approach, 
recent evidence on the molecular pathways linking NST and obesity in mammals, 
focusing on the mechanisms involved in BAT development. Our results, summarised 
in Fig. 2, demonstrated that molecules such as fatty acid-binding protein 3 
(Yamashita et al. 2008), cardiac natriuretic peptides (Bordicchia et al. 2012), Pinellia 
ternate extract (Kim et al. 2006), L-menthol (Ma et al. 2012), progesterone (Rose et 
al. 2011), bone morphogenetic protein 7 (Tseng et al. 2008), PPAR-γ (Gray et al. 
2006), placenta-specific 8 (Jimenez-Preitner et al. 2011), T3 (Lehr et al. 2009), Sirt3 
(Giralt et al. 2011), period2 (Chappuis et al. 2013) as well as cold stimuli (Barger et 
al. 2006; Liu et al. 2009; Zhang et al. 2009; Chappuis et al. 2013; van der Lans et al. 
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2013; Yoneshiro et al. 2013) can increase UCP1 expression in existing brown 
adipocytes (Fig. 2: mechanism A).  
 
Figure 2. Schematic representation of the effect of specific molecules, hibernation, and cold 
on brown adipose tissue (BAT)/brite development, non-shivering thermogenesis (NST) 
stimulation and adiposity based on the results of the present systematic analysis. In 
mechanism A, cold stimuli or specific molecules activate uncoupling protein-1 (UCP1) in the 
existing brown adipocytes. In mechanism B, certain molecules or cold exposure stimulate 
brite cell development, increasing the number of brite cells (i.e. brite mass) and the 
expression of UCP1 in brite adipocytes. In mechanism C, specific molecules, or hibernation, 
or cold exposure lead to increased BAT mass. The up-regulation of UCP1 expression in 
brown (mechanism A) and brite (mechanism B) adipocytes enhances NST and energy 
expenditure (EE). Finally, all three mechanisms can lead to augmented BMR and reduced 
adiposity levels in mammals when frequent NST stimulation without food intake compensation 
occurs. * = without food intake compensation; ↑ = increase; ↓ = decrease; BMP-7 = bone 
morphogenetic protein 7; BMR = basal metabolic rate; FABP3 = fatty acid-binding protein 3; 
NPs = natriuretic peptides; PE = Pinellia ternate extract; Per2 = Period2; Plac8 = placenta-
specific 8; PPAR-γ = peroxisome proliferator-activated receptor γ; Rald = retinaldehyde 
dehydrogenase 1; Sirt3 = silent mating type information regulation 2, homolog 3; T3 = tri-
iodothyronine.  
Specific molecules such as PPAR-γ (Gray et al. 2006), placenta-specific 8 (Jimenez-
Preitner et al. 2011), Rald (Kiefer et al. 2012), T3 (Lehr et al. 2009), cardiac 
natriuretic peptides and cold exposure (Bordicchia et al. 2012) are implicated in brite 
cell development (Fig. 2: mechanism B). In turn, this leads to enhanced numbers of 
brite cells (i.e. brite mass) in WAT that contribute to increased UCP1 expression in 
WAT. It is important to note that the effect of cold exposure on white-to-brite 
transdifferentiation has been confirmed in rodents (Bordicchia et al. 2012), yet further 
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research is required to assess its efficacy in humans (van der Lans et al. 2013). On 
the other hand, cold exposure as well as molecules such as Sirt3 (Giralt et al. 2011), 
bone morphogenetic protein 7 (Tseng et al. 2008), PPAR-γ (Gray et al. 2006), 
placenta-specific 8 (Jimenez-Preitner et al. 2011), and T3 (Lehr et al. 2009) stimulate 
brown adipocyte differentiation (Fig. 2: mechanism C), leading to augmented BAT 
mass. Interestingly, the increase in BAT mass can also emerge from hibernation 
(Kitao and Hashimoto 2012) (Fig. 2: mechanism C), a concept discussed further 
below. The up-regulation of UCP1 gene and protein expression in brown and brite 
adipocytes through the aforementioned mechanisms A and/or B, respectively, leads 
to augmented NST and EE. Finally, frequent NST stimulation can result, eventually, 
in a rise of BMR and a reduction in adiposity levels (Koutedakis et al. 2005; 
Feldmann et al. 2009; Shabalina et al. 2010; Carrillo and Flouris 2011). 
It is worth noting that the evaluated studies suggest that specific molecules 
such as fatty acid-binding protein 3 (Yamashita et al. 2008), Pinellia ternate extract 
(Kim et al. 2006), L-menthol (Ma et al. 2012), and progesterone (Rose et al. 2011) 
are involved in the activation of UCP1 in the existing brown adipocytes (Fig. 2: 
mechanism A) but do not contribute to BAT mass development. Thus, their effects on 
NST and metabolism depend on the available number of brown adipocytes. This is 
confirmed by the finding that cold exposure generates greater NST response and 
body mass reduction in hibernating animals that demonstrate larger BAT mass 
compared to warm- or cold-acclimated animals that demonstrate lower BAT mass 
(Kitao and Hashimoto 2012). 
The transdifferentiation of white adipocytes to brite adipocytes (i.e. increasing 
brite mass) in mammals is a crucial step in the process towards increasing NST and 
metabolism, given the key role of brite mass in UCP1 expression. Stimulating a 
larger mass of cells to express UCP1 results in a more prominent increase of NST 
(Kitao and Hashimoto 2012) thus augmenting total EE by a magnitude proportional to 
the number of available brown and brite adipocytes. Moreover, frequent NST 
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stimulation, without food intake compensation, may lead to body mass loss. Several 
early studies showed that BAT is present in adult humans (Heaton 1972; Huttunen et 
al. 1981; Astrup et al. 1985) and that it is highly correlated with body mass index 
(Vijgen et al. 2011). Individuals with a larger BAT mass demonstrate greater cold-
induced thermogenesis, EE, and BAT activity following cold exposure (Vijgen et al. 
2011). Therefore, the increase of BAT/brite mass (through mechanisms B and C in 
Fig. 2) as well as frequent NST stimulation (through mechanisms A and B) may be 
promising in obesity treatment. 
The current analysis produced an interesting concept regarding human brite 
cell development: one of the analysed studies showed that Rald (a molecule included 
in mechanism B of Fig. 2) induces white-to-brite transdifferentiation in human white 
adipocytes. This occurs by stimulating the WAT expression of the zinc-finger protein 
PR domain containing 16 (Kiefer et al. 2012). The latter is known to increase directly 
– or indirectly through the activation of PGC-1α – the type 2 deiodinase expression 
(Seale et al. 2007) that catalyses the conversion of thyroxine in T3 (Hall et al. 2010). 
Interestingly, several animal studies analysed herein suggested that T3 (Fig. 2: 
mechanism B) augments brite cell development, UCP1 transcription, NST, and EE 
resulting in lower adiposity levels (Lehr et al. 2009; Hall et al. 2010; De Jonghe et al. 
2011; Chen et al. 2012). It is, therefore, logical to suggest that Rald may induce brite 
cell development in human WAT though the stimulation of thyroid hormone T3. 
However, the validity of this hypothesis remains to be confirmed by future research. 
 Systematic reviews determine the information to be obtained from a literature 
analysis using explicit inclusion and exclusion criteria (e.g. key words, years, and 
languages). Thus, the advantage of using a systematic analysis lies in reducing the 
likelihood of bias in identifying, selecting, and aggregating individual studies 
(Wieseler and McGauran 2010). While the systematic approach is likely to produce 
more accurate results regarding the effects of a specific phenomenon across a wide 
range of settings and empirical methods, it incorporates the risk of not including 
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relevant studies due to inadequate or incorrect methodology. In the present review 
we made considerable efforts to minimise these shortcomings by adopting published 
guidelines (Wieseler and McGauran 2010), using appropriate key words, and 
searching two of the largest databases available. Our systematic review is not a 
catalogue of everything that has been done, but rather a systematic synthesis of the 
work conducted since 2006 – the year when UCP1 was suggested to be the only 
mediator of NST in mammalian BAT (Barger et al. 2006). We attempted to ensure 
that our work provides concrete and unbiased added value and substance, draws 
together knowledge and highlights critical advances, thus creating new knowledge. In 
this light, our analysis suggests that future research in both animals and humans 
should address the interplay between body mass, BAT mass, as well as the main 




(1) Specific molecules can enhance NST and metabolism by: (i) stimulating brite cell 
development in white adipose tissue, (ii) increasing UCP1 expression in brite 
adipocytes and in existing brown adipocytes, and (iii) augmenting BAT/brite mass. 
(2) BAT mass also can be increased through low temperature, hibernation, and/or 
molecules involved in brown adipocyte differentiation. 
(3) Cold stimuli and/or certain molecules activate UCP1 in existing brown adipocytes, 
thus increasing total energy expenditure by a magnitude proportional to the number 
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We investigated the absorption and metabolism pharmacokinetics of a single L-
menthol oral versus skin administration and the effects on human thermogenesis and 
metabolic rate. Twenty healthy adults were randomly distributed into oral (capsule) 
and skin (gel) groups and treated with 10 mg·kg-1 L-menthol (ORALMENT; SKINMENT) 
or control (lactose capsule: ORALCON; water application: SKINCON) in a random order 
on two different days. Levels of serum L-menthol increased similarly in ORALMENT 
and SKINMENT (p>0.05). L-menthol glucuronidation was greater in ORALMENT than 
SKINMENT (p<0.05). Cutaneous vasoconstriction, rectal temperature and body heat 
storage showed greater increase following SKINMENT compared to ORALMENT and 
control conditions (p<0.05). Metabolic rate increased from baseline by 18% in 
SKINMENT and 10% in ORALMENT and respiratory exchange ratio decreased more in 
ORALMENT (5.4%) than SKINMENT (4.8%) compared to control conditions (p<0.05). 
Levels of plasma adiponectin and leptin as well as heart rate variability were similar 
to control following either treatment (p>0.05). Participants reported no cold, shivering, 
discomfort, stress or skin irritation. We conclude that a single L-menthol skin 
administration increased thermogenesis and metabolic rate in humans. These effects 
are minor following L-menthol oral administration probably due to faster 
glucuronidation and greater blood menthol glucuronide levels. 
 
KEYWORDS: brown adipose tissue; non-shivering thermogenesis; UCP1; partitional 
calorimetry; energy consumption; cardiovascular diseases.  
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Uncoupling protein 1 (UCP1) is the main player in non-shivering thermogenesis 
(NST) process which takes place in mammal brown and brown-like (beige) 
adipocytes (Feldmann et al. 2009). Frequent stimulation of UCP1 results in an 
increase of basal metabolic rate and a reduction of adiposity levels in rodents as the 
fat energy storage is used for body heat production (Inokuma et al. 2006; Yamashita 
et al. 2008; Feldmann et al. 2009; Yoneshiro et al. 2013; Valente et al. 2014). 
Specifically, the oxidation of free fatty acids generates an electrochemical gradient 
across the mitochondrial inner membrane and when protons bypass the ATP 
synthase entrance and return to the mitochondrial matrix through UCP1, the energy 
of the electrochemical gradient is dissipated as heat (Feldmann et al. 2009; Mattson 
2010). Animal studies reported that L-menthol is one of the molecules involved in the 
activation of UCP1 through the stimulation of the transient receptor potential 
melastatin 8 ion channel (Tajino et al. 2007; Ma et al. 2012; Valente et al. 2014). This 
receptor is the principal sensor of thermal stimuli in the peripheral nervous system 
(Romanovsky 2007; Flouris 2011). It is predominantly located on the cell membrane 
of sensory neurons while its expression has also been recently discovered on the 
membrane of brown and white adipocytes (Wang and Woolf 2005; Bautista et al. 
2007; Colburn et al. 2007; Dhaka et al. 2007; Tajino et al. 2011; Ma et al. 2012; 
Rossato et al. 2014). Once in the body, L-menthol stimulates its receptor and induces 
a reversible rise in the intracellular Ca2+ with a subsequent protein kinase A 
phosphorylation in brown adipocytes that leads to UCP1 activation (Ma et al. 2012). 
This effect on Ca2+ current and UCP1 activation is stereochemically selective as D-
menthol is half as active as its stereoisomer L-menthol (Wright et al. 1998).  
A single application of L-menthol to the skin of the whole trunk in mice 
induces heat production and a rise in core temperature through skin vasoconstriction, 
muscle shivering, and NST activity (Tajino et al. 2007). Moreover, a 7-month dietary 
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L-menthol administration in mice increases core temperature, UCP1 expression in 
brown adipose tissue (BAT), NST activity and insulin sensitivity leading to attenuated 
body weight gain (Ma et al. 2012). 
Similarly to rodents, a single skin L-menthol application in humans evokes 
cold sensation and cutaneous vasoconstriction (Yosipovitch et al. 1996; Olive et al. 
2010; Topp et al. 2011; Gillis et al. 2015). A single oral administration of L-menthol, 
however, does not influence blood pressure or skin temperature (Gelal et al. 1999).  
Pharmacokinetics results show that, when taken orally, L-menthol is rapidly absorbed 
from the small intestine and extracted in the urine predominantly (~65%) as menthol 
glucuronide (Hiki et al. 2011). These findings suggest that the glucuronidation 
process which leads to low levels of L-menthol in the blood, may attenuate the 
aforementioned physiological effect upon oral L-menthol administration. Interestingly, 
the recent discovery of BAT and the white to brown-like transdifferentiation process 
in adult humans has provoked a plethora of theories and scientific experiments on its 
metabolic capabilities and potential for increasing energy expenditure (van Marken 
Lichtenbelt et al. 2009; Virtanen et al. 2009; Muzik et al. 2012; Rossato et al. 2014; 
Dinas et al. 2015; Flouris and Dinas 2015). Indeed, a recent in vitro study on human 
white adipocytes reported that L-menthol induces white to brown-like adipocyte 
transdifferentiation, stimulates UCP1 expression in brown-like adipocytes, and 
increases glucose uptake and heat production (Rossato et al. 2014). These findings 
emphasize the requirement of in vivo studies to confirm L-menthol as a potential 
molecule involved in controlling energy metabolism in humans. However, no 
physiological or clinical data are available on the effect of L-menthol on NST and 
energy expenditure in humans as well as on the comparison between oral and skin 
L-menthol administration in eliciting these effects. 
The purpose of the present study was to compare, for the first time, the 
absorption and metabolism pharmacokinetics of a single L-menthol oral versus skin 
administration and investigate their effects on thermogenesis and metabolic rate in 
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healthy men and women. Based on previous animal studies assessing the effects of 
a single skin and daily oral L-menthol administration on NST and metabolism 
(Yosipovitch et al. 1996; Gelal et al. 1999; Tajino et al. 2007; Olive et al. 2010; Topp 
et al. 2011; Ma et al. 2012; Rossato et al. 2014; Valente et al. 2014) as well as 
considering the increase in human cutaneous vasoconstriction and rectal 
temperature upon a single skin L-menthol administration, we hypothesized that both 
oral and skin L-menthol administration would increase thermogenesis and metabolic 
rate in humans. Moreover, considering a limited contribution of the skin to the body's 
total phase II drug metabolism in humans (Manevski et al. 2015), L-menthol 
transdermal absorption may attenuate and/or delay the glucuronidation process 
leading to the entrance of a greater amount of L-menthol into the bloodstream 
compared to gastrointestinal absorption (Gelal et al. 1999; Hiki et al. 2011). 
Therefore, we also hypothesized that the skin administration would be more potent at 





The study conformed to the standards set by the Declaration of Helsinki and was 
approved by the University of Thessaly Department of Exercise Science Ethics 
Committee. A minimum required sample size of <5 participants per group was 
determined (statistical power: 0.95; α error probability: 0.05) based on plasma 
menthol glucuronide concentration observed before (17.8 ± 13.9 ng/ml) and 1 hour 
after (5617.5 ± 1918.1 ng/ml) a single oral L-menthol administration in a previously-
published study (Hiki et al. 2011). Thus, 10 male and 10 female healthy volunteers 
[25.3 ± 6.2 years, 23.8 ± 3.0 kg·m2 body mass index (BMI), 20.2 ± 9.9 body fat 
percentage (mean ± standard deviation)] were recruited for this study. All volunteers 
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were recreationally active individuals and none of them were competitive athletes. 
Exclusion criteria included smoking, history or presence of metabolic, cardiac or 
pulmonary disease, thyroid or thermoregulatory disorders, use of any medication or 
oral contraception and pregnancy for females. Participants were informed about all 
experimental procedures, associated risks and discomforts and were asked to 
provide written informed consent. Female participants were tested during the early 
follicular phase (days 1-6) of their menstrual cycle. 
Volunteers were randomly placed into the oral (ORAL) or skin (SKIN) 
administration group, each consisting of 10 participants. The study was conducted 
between June 2013 and June 2014 and participants of the two groups (ORAL and 
SKIN) were randomly allocated among the four seasons and tested for both control 
and L-menthol administration within 4-6 days. The randomization of the participants 
into the two groups as well as among seasons was performed using a random 
allocation algorithm incorporated in the SPSS Statistics Software (version 19; SPSS 
Inc., Chicago, IL, USA) in order to eliminate the eventual effects of adaptation/stress 
to the experimental procedures as well as to season temperature on the obtained 
results. No differences in age (ORAL: 26.2 ± 8.0 years; SKIN: 24.4 ± 3.9 years), body 
weight (ORAL: 65.9 ± 11.9 Kg; SKIN: 77.0 ± 11.3 Kg), height (ORAL: 1.7 ± 0.1 m; 
SKIN: 1.8 ± 0.1 m), BMI (ORAL: 22.6 ± 2.1 Kg∙m2; SKIN: 25 ± 3.4 Kg∙m2), or body fat 
percentage (ORAL: 17.8 ± 6.8 %; SKIN: 22.6 ± 12.1 %), were detected between the 
two groups (mean ± SD, p>0.05). Participants in the ORAL group were administered 
L-menthol (ORALMENT) via a capsule containing 10 mg·kg
-1 body weight of L-menthol 
crystals (natural L-menthol FU-BP-USP; A.C.E.F. spa, Fiorenzuola d’Arda, Italy). 
This represents the highest daily orally dose that has been safely administrated to 
humans (Eisenberg et al. 1955). Participants in the SKIN group were administered L-
menthol (SKINMENT) by applying a gel on skin surface of the neck and right arm and 
leg containing the same relative amount of L-menthol crystals (i.e., 10 mg·kg-1 body 
weight). The L-menthol gel was formulated according to previously published 
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procedures (Kounalakis et al. 2010) by mixing 10 mL of warm water (~40°C) and 
crystals of L-menthol for five minutes immediately prior to application.  Both groups 
also completed a control treatment that consisted of a capsule containing lactose for 
the ORAL group (ORALCON) and warm water (~40°C) application for the SKIN 
(SKINCON). The administration of L-menthol or control was conducted in a random 
order on two different days separated by at least 72 hours. All measurements 
(described in the following paragraphs) were conducted by the same trained 
researchers using identical pre-calibrated equipment. Double-blind procedures were 
adopted only in the ORAL group. Due to the strong smell of menthol, a double-blind 
design was not possible in the SKIN group. 
 
Experimental procedures  
For each participant, the dietary intakes of the day before each administration (i.e., 
control or L-menthol oral administration as well as control or L-menthol skin 
administration) were similar. Indeed, on the day before to the first administration (i.e., 
control or L-menthol), participants chose their food consumption recording all the 
nutrients and the relative amount of their dietary intake using a log as well as their 
physical activity using a pedometer (Digi-Walker SW–200, Yamax, United Kingdom). 
These data were used as a guide for the participants to follow during the day prior to 
the second administration, and they were asked to adhere to it as much as possible. 
All participants were asked to not consume any products containing menthol, abstain 
from alcohol, caffeine, and environmental tobacco smoke, avoid any physical or 
mental stress and extreme temperature environments, and fast for 12 hours prior to 
each administration. Moreover, the National Weather Service Website was used to 
record the environmental temperature in the surrounding area of the day before each 
administration (i.e., control or L-menthol) for both groups (ORAL or SKIN). 
 During the treatment days, participants were asked to report to the laboratory 
(which was maintained at 25.1 ± 0.9 °C and 35.8 ± 3.4 % relative humidity during the 
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entire assessment period) at 08:30 following a 12-hr fast. They were asked to refrain 
from excessive stressors between wake-up time and arrival at the laboratory. All 
participants were transported to the laboratory via car and they were asked to wear 
the same clothing for both treatment days. Food consumption was not permitted 
during data collection. Although room-temperature water was provided ad libitum, 
Mann-Whitney U test showed that participants in ORAL (151 ± 78.0 g) and SKIN 
(220 ± 83.6 g) groups consumed the same quantity during treatment days (p>0.05).  
After the participant’s arrival in the lab, body mass and body fat percentage 
were assessed using a body composition analyser (Tanita BF522W, Tokyo, Japan). 
Rectal temperature (Tre), skin blood flow (SkBF), mean skin temperature (Tsk), and 
body heat storage (S) were assessed to determine the effect of L-menthol 
administration on thermogenesis, while metabolic rate (M) and respiratory exchange 
ratio (RER) were measured to determine the effect of L-menthol on metabolism and 
substrate utilization. Therefore, various sensors for these physiological variables 
measurements were applied on the participants’ body. Specifically, a thin and flexible 
core temperature thermistor (Mon-A-Therm Core, Mallinkrodt Medical, St Louis, 
USA) was self-inserted 15 cm beyond the anal sphincter to measure Tre every 8 sec 
using the BioTempTM (model 3.1, Biomnic Ltd., Greece), as previously described 
(Hartley et al. 2012). A laser-Doppler velocimetry (PeriFlux System 5000, main 
control unit; PF5010 LDPM, function unit; Perimed, Stockholm, Sweden) was applied 
on the epidermis at the distal end of the left first toe (i.e. hallux) to measure SkBF, 
using previous procedures (Flouris and Cheung 2009). The probe (PR 407 small 
straight probe; Perimed) was held in place with a plastic apparatus (diameter: 5 mm; 
PH 07-5; Perimed) and double-sided adhesive strips (PF 105-3; Perimed). The Tsk, 
S, M and RER were measured non-invasively using partitional calorimetric 
techniques. Seven pre-calibrated heat flow sensors incorporating temperature 
thermistors were placed on the skin surface of the forehead, abdomen, forearm, 
hand, quadriceps, shin, and foot and held in place with surgical tape (Leukoplast, 
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BSN medical, Hamburg, Germany) and were used to record data every 8 sec using 
the BioTempTM (model 3.1, Biomnic Ltd., Greece). Moreover, to assess autonomic 
modulation, participants were outfitted with a heart rate chest strap and heart rate 
variability (HRV) was measured through short-range telemetry at 1,000 Hz with a 
Polar RS800CX (Polar Electro, Kempele, Finland). 
At 09:45, participants were asked to sit on a comfortable chair and remain 
seated for the next 7 hours and 30 min. For all participants, data collection started at 
09:45 and the first 15 minutes (i.e., 09:45-10:00) were used as baseline data. The 
treatment (i.e., L-menthol or control) was always administered at 10:00 which 
consisted of ingestion of the L-menthol/lactose capsules for participants in ORAL and 
application of L-menthol gel/water to the back of the neck and the front of the right 
arm and leg for SKIN participants. Data collection (the first 15 min of every hour) 
continued for 7 hours and 15 minutes (i.e., from 10:00 until 17:15) following the 
administration of the treatment. During data collection participants were instructed to 
remain silent and as calm and still as possible while between measurements, 
participants remained seated and either were watching a movie or reading a book. 
Following the final data collection (i.e., 17:00-17:15), all sensors were removed and 
the participants were discharged. 
 
Blood biomarkers 
Four venous blood samples (~10 mL each) were collected from an antecubital vein at 
baseline and at 1, 2, and 6 hours following each administration and then separated in 
serum-separator and EDTA tubes. The serum-separator-samples were first kept at 
room temperature for ~20 min before centrifugation at 3000 rpm for 10 min at 4°C 
while the EDTA-samples were immediately centrifuged at 3000 rpm for 10 min at 
4°C. The serum and plasma supernatants were collected and stored at -80°C until 
analysis. 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 08:36:14 EEST - 137.108.70.13
51 
 
Serum samples were analysed for L-menthol and its primary metabolite, 
menthol glucuronide that was calculated as the difference in L-menthol 
concentrations before and after the samples were treated with β-glucuronidase. 
Specifically, for the determination of free L-menthol, 1 mL of serum was placed in an 
8 mL solid phase microextraction vial. One ml of ultrapure water, 0.25 gr of NaCl and 
40 ng of internal standard 1,2,3,4-tetrachloronaphthalene (TCN) were added. For the 
determination of total L-menthol 1 mL of serum, 0.25 gr NaCl, 875 μL of buffer 
solution pH=6 (Carl Roth GmbH), 25 μL of the β-glucuronidase enzyme (Type HP-2, 
Helix pomatia, Sigma), 100 μL of ultrapure water and 40 ng of TCN were placed in 
solid phase microextraction vials (Hiki et al. 2011). Solid phase microextraction vials 
were sealed with polytetrafluoroethylene/silicon septum caps and placed in a gas 
chromatography-mass spectrometry tray. Online extraction followed with a 
polydimethylsiloxane/divinylbenzene type extraction fibre at 50°C for 30 min with an 
agitation speed of 250 rpm. After the completion of the absorption process, the fibre 
tip was inserted in the injection port of the gas chromatography-mass spectrometry, 
where it remained for 3 min until the complete release of the analytes. Serum 
samples with no detected levels of L-menthol were used as blank samples, fortified 
at different concentration levels (0, 1, 2, 5, 10, 20, 40 and 80 ng/mL for free L-
menthol and 0, 5, 10, 20, 40, 80, 160, 320, 640 and 1280 ng/mL for total L-menthol) 
and used as spiked samples for the preparation of the calibration curves. Samples 
were analysed with a Shimadzu (Kyoto, Japan) QP-2010 gas chromatography-mass 
spectrometry equipment. The system was equipped with a split/splitless injection inlet 
and an AOC-5000 robotic autosampler with the appropriate functions to operate in 
solid phase microextraction mode. Gas chromatography-mass spectrometry solution 
software was used for instrument control and data analysis. Gas chromatography 
analysis was conducted on a Supelco SLBtm-5ms (Bellefonte PA, USA) capillary 
column of 30 m length, 0.25 mm i.d, and 0.25 µm film thicknesses. The AOC-5000 
solid phase microextraction autosampler was equipped with a syringe with a 65 um 
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polydimethylsiloxane/divinylbenzene Metal Alloy fibre from Supelco (Bellefonte PA, 
USA). The following conditions were used: Helium with a constant flow rate of 1 
mL/min as a carrier gas, inlet temperature 250°C, splitless injection for 1 min, mass 
spectrometer interface and ion source temperatures were 300°C and 220°C, 
respectively. The column temperature was initially held at 65°C for 5 min, raised at 
10°C·min-1 to 140°C and increase at a rate of 30°C·min-1 until 310°C were it 
remained for 2 min. Under the above conditions the retention times of L-menthol and 
internal standard were 11.80 and 17.57 min, respectively. The mass spectrometer 
detector was operated at the selected ion-monitoring mode (SIM). The qualification 
m/z ions of L-menthol were m/z=71, 81, 95, 123 and 138 (with target ion m/z=95) 
while the m/z ions for internal standard were 266 and 194 (with target ion 266). 
The plasma samples were analysed for adiponectin (Human 
adiponectin/Acrp30 ELISA, order number RAB0005, analytical sensitivity <25 pg/mL, 
intra assay <10%, inter assay <12%; Sigma-Aldrich, St Louis, MO 63013, USA) and 
leptin concentration (Human Leptin ELISA, order number RAB0333, analytical 
sensitivity <2 pg/mL, intra assay <10%, inter assay <12%; Sigma-Aldrich, St Louis, 
MO 63013, USA) – being both hormones involved in UCP1 activity (Asano et al. 
2013; Qiao et al. 2014), regulation of energy expenditure and glucose and fatty acid 
breakdown (Giby and Ajith 2014) – using commercially available ELISA kits that were 
performed according to the instructions of the manufacturer. Briefly, all plasma 
samples were diluted 30000 times for adiponectin and 20 times for leptin with sample 
diluent before performing each hormone analysis. Standard series and samples were 
added in duplicate to the plate and adiponectin or leptin presented in each sample 
was bound to the wells by the corresponding immobilized antibody. The wells were 
washed with a washing solution and biotinylated anti-human adiponectin or leptin 
antibodies were added. After washing away unbound biotinylated antibody, 
horseradish peroxidase-conjugated streptavidin was pipetted to the wells. The wells 
were again washed, a 3,3′,5,5′-tetramethylbenzidine substrate solution was added to 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 08:36:14 EEST - 137.108.70.13
53 
 
the wells and colour developed in proportion to the amount of adiponectin or leptin 
bound. The stop solution changed the colour from blue to yellow, and the intensity of 
the colour was measured at a wavelength of 450 nm.  
 
Thermal comfort and sensation  
At the beginning of baseline and each data collection time, participants were asked to 
indicate a number for thermal comfort and thermal sensation using previously 
published scales (Gagge et al. 1969). The range of the thermal comfort scale was 
from 1 through 5, where 1 = “comfortable”, 2 = “slightly uncomfortable”, 3 = 
“uncomfortable”, 4 = “very uncomfortable”, 5 = “extremely uncomfortable”; 
participants could also indicate intermediate numbers (i.e., 1.5, 2.5, 3.5, and 4.5). 
The range of the thermal sensation scale was from 0 through 10, where 0 = 
“unbearably cold”, 1 = “very cold”, 2 = “cold”, 3 = “cool”, 4 = “slightly cool”, 5 = 
“neutral”, 6 = “slightly warm”, 7 = “warm”, 8 = “hot”, 9 = “very hot”, 10 = “unbearably 
hot”. Moreover, during the entire assessment period, participants were frequently 
asked to report any kind of stress, discomfort, and/or shivering. Moreover, 
participants in the SKIN group were also constantly inspected for skin irritation. 
 
Data computations  
Physiological data (i.e., SkBF, Tsk, Tre, S, M, RER, and HRV indices) were used to 
calculate 1-min averages for each 15-min data collection time point. Thereafter, 
these values were used for subsequent computations as described below. Data for 
total L-menthol and free L-menthol concentrations were used to calculate menthol 
glucuronide concentration. The serum concentration of total L-menthol represents the 
total L-menthol absorption, the free L-menthol serum concentration represents the 
amount of L-menthol in the body, while the serum menthol glucuronide concentration 
is an indicator of the metabolism of L-menthol. 
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Partitional calorimetric estimates of the rates of heat storage were calculated 
according to the conceptual heat balance equation:  
S = M - W (C + R + Esk + Cres + Eres) (W∙m
-2) 





0.3 ) ∙ ec + (
1 − RER
0.3 ) ∙ ef




where VO2 is the rate of oxygen consumption (mL∙min
-1); RER is the respiratory 
exchange ratio (non-dimensional); while ec and ef are the energetic equivalents of 
carbohydrate (21.116 kJ∙L-1 O2) and fat (19.606 kJ∙L
-1 O2), respectively. The VO2 and 
RER were based on indirect calorimetry data obtained as participants breathed 
(during data collection time) through a low resistance one-way valve attached to a 
face mask. Exhaled gases were assessed using a gas analyser (Oxycon Mobile, 
CareFusion, San Diego, USA) and RER was calculated as the ratio between CO2 
removed from the body and O2 consumed. External workload (W) was 0 as the 
participants remained relaxed in a seated position throughout the experiment. 
The combined respiratory heat exchange via convection (Cres) and 
evaporation (Eres) was calculated as: 
Cres + Eres = [0.0014 ∙ Hp ∙ (34 – Ta)] + [0.0173 ∙ Hp ∙ (5.87 – Pa)] (W∙m
-2) 
where Hp is the rate of metabolic heat production calculated as the difference 
between M and W (in W∙m-2); Ta is the ambient temperature (°C); and Pa is the 
ambient vapour pressure in kilopascals (kPa). 
Heat exchange via convection (C) and radiation (R) was calculated as: 





 (W ∙ m−2) 
where: Rcl is the thermal resistance of clothing (m
2∙°C∙W–1) which was assumed to be 
negligible due to minimal clothing insulation (i.e., ~0.2-0.3 clo) and, in any case, 
systematic as participants wore the same clothing on both assessment days; fcl is the 
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non-dimensional area-weighted clothing factor (assumed to be 1.0 with minimal 
clothing); h is the combined heat transfer coefficient (W∙m-2∙°C-1) calculated as the 
sum of convective (hc) and radiant (hr) heat transfer coefficients (see calculation 
procedures below). The operative temperature (To) was estimated as: 
To =
hc ∙ Ta + hr ∙ Tr
hr + hc
 (℃) 
where Tr is the radiant temperature (°C) assumed to be equal to Ta. 
The hc and hr were calculated as follows: 
hc = 8.3v









 (W ∙ m−2 ∙ ℃−1) 
where: v is air velocity (m∙s–1); ε is the area-weighted emissivity of the skin, estimated 
as 0.95; σ is the Stefan-Boltzmann constant (5.67∙10–8 W∙m–2∙°C–4);  
Ar
AD
 is the 
effective radiant surface area (non-dimensional), estimated to be 0.7 for a seated 
individual (Fanger 1970); and Tcl is the temperature of the clothing (°C) which was 
assumed to be equal to Tsk. Evaporative heat loss was assumed to be negligible as 
no sweating was apparent. 
For the HRV analysis, the heart rate monitor signal was transferred to the 
Polar Precision Performance Software (release 3.00; Polar Electro Oy), and RR 
intervals (time intervals between consecutive R waves in the electrocardiogram) were 
analysed in order to assess the modulation of sympathetic and parasympathetic 
activities as previously described (Flouris and Cheung 2009). Frequency domain, 
time domain and nonlinear method analysis was performed using HRV software 
version 1.1 (Finland; Biomedical Signal Analysis Group, Department of Applied 
Physics, University of Kuopio, Finland 2002) evaluating the RR interval time series 
automatically obtained from the raw signals (Rajendra Acharya et al. 2006). The 
frequency domain with the low frequency, high frequency, and low frequency to high 
frequency ratio variables were analysed to discriminate between sympathetic and 
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parasympathetic contribution to HRV. For the time domain method, both statistical 
and geometric parameters were considered for the analysis of Mean RR, Mean HR, 
standard deviation of RR and heart rate, the square root of the mean of squared 
differences between successive intervals, the percentage of the differences of 
successive normal-to-normal intervals 50 ms normalized to all differences within the 
interval, the number of pairs of successive normal-to-normal that differ by more than 
50 ms, the HRV triangular index, and the triangular interpolation of normal-to-normal 
interval histogram. Nonlinear method was used to analyse the standard deviation of 
fast and long term RR variability, mean line length, maximum line length, recurrence 
rate, determinism, Shannon Entropy, approximate entropy, sample entropy, 
Detrended Fluctuation Analysis α 1 and 2, and correlation dimension. 
 
Statistical analyses 
Environmental temperature in the surrounding area of the day before each 
administration and all dependent variables (serum L-menthol and menthol 
glucuronide, plasma adiponectin, leptin and leptin/adiponectin ratio as well as SkBF, 
Tsk Tre, S, M, RER, HRV, thermal comfort and thermal sensation) showed a non-
normal distribution therefore non-parametric tests were used throughout. Mann-
Whitney U and Wilcoxon Signed-Rank tests were used to compare environmental 
temperatures in the surrounding area between groups for the same treatment (i.e., 
ORALMENT vs. SKINMENT and ORALCON vs. SKINCON) and between treatments within 
the same group (i.e., ORALCON vs. ORALMENT and SKINCON vs. SKINMENT), 
respectively. Moreover, for each dependent variable, Mann–Whitney U tests were 
used for the comparisons between groups for the same treatment (i.e., ORALMENT vs. 
SKINMENT and ORALCON vs. SKINCON) at baseline and each assessment hour 
separately. Wilcoxon Signed-Rank test was used for the comparisons between 
treatments within the same group (i.e., ORALCON vs. ORALMENT and SKINCON vs. 
SKINMENT) at baseline and each assessment hour separately as well as to assess 
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dependent variables differences across time (i.e., differences between baseline and 
each following assessment hour as well as between consecutive assessment hours 
within each treatment). All analyses were conducted with SPSS Statistics (version 
19; SPSS Inc., Chicago, IL, USA). The data are reported as mean ± SEM and p-
values < 0.05 were regarded as statistically significant. We did not adjust for multiple 
comparisons in our study due to the errors and misplaced emphasis associated with 
such procedures when applied in actual natural observations (Rothman 1990; 




Environmental temperatures in the surrounding area 
In order to test our primary and secondary hypothesis, we first examined the impact 
of the environmental temperature in the surrounding area. Mann-Whitney U and 
Wilcoxon Signed-Rank tests showed that the environmental temperature in the 
surrounding area on the day before each administration were not significant different 
(p>0.05) between groups for the same treatment (i.e., ORALMENT: 20.5 ± 1.7 °C vs. 
SKINMENT: 16.4 ± 1.8 °C; ORALCON: 19.8 ± 2.0 °C vs. SKINCON 15.6 ± 1.6 °C) and 
between treatments within the same group (i.e., ORALCON: 19.8 ± 2.0 °C vs. 
ORALMENT: 20.5 ± 1.7 °C; SKINCON: 15.6 ± 1.6 °C vs. SKINMENT: 16.4 ± 1.8 °C).  
 
Serum L-menthol and menthol glucuronide concentration 
Regarding our primary hypothesis, results from Wilcoxon Signed-Rank tests 
demonstrated that L-menthol and menthol glucuronide concentrations were 
significantly different between treatments within the same group (i.e., ORALCON vs. 
ORALMENT and SKINCON vs. SKINMENT) (Figure 1, p<0.05). Regarding our secondary 
hypothesis, results from Mann-Whitney U tests demonstrated that menthol 
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glucuronide concentrations (p<0.05) but not L-menthol (p>0.05), were significantly 
different between groups for the same treatment (i.e., ORALMENT vs. SKINMENT). 
Specifically, the body absorption of L-menthol (i.e., total L-menthol) was higher in 
ORALMENT (3385.9 ± 1681.1 ng/mL) compared to SKINMENT (214.8 ± 112.7 ng/mL) 
(Figure 1, p<0.05). The changes observed in the amount of L-menthol in the body 
(i.e., free L-menthol) were similar in ORALMENT and SKINMENT (p>0.05), showing an 
increase within 1 hour after treatments (Figure 1, p<0.05). Within 1 hour after 
ORALMENT, menthol glucuronide was ~38.0 times higher than L-menthol (3299.6 ± 
1636.3 ng/mL menthol glucuronide and 86.4 ± 44.7 ng/mL L-menthol) (Figure 1). 
 
Figure 1. Results (mean ± SEM) and comparisons for serum L-menthol and menthol 
glucuronide levels at baseline (Base) and 1, 2 and 6 hours after oral and skin treatments. 
Note: * = significant differences from baseline within the same treatment (Wilcoxon Signed-
Rank tests; p<0.05); ǂ = significant differences from the previous time-point within the same 
treatment (Wilcoxon Signed-Rank tests; p<0.05); † = significant differences between control 
and L-menthol treatments within the same group for the same time-point (Wilcoxon Signed-
Rank tests; p<0.05); Ṩ = significant differences between SKIN vs. ORAL group for the same 
treatment and time-point (Mann-Whitney U tests; p<0.05). 
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The peak of menthol glucuronide (4201.2 ± 2189.9 ng/mL) was reached 2 hours after 
ORALMENT (Figure 1, p<0.05). On the other hand, within 1 hour after SKINMENT, 
menthol glucuronide was ~1.2 times smaller than L-menthol (95.5 ± 69.7 ng/mL 
menthol glucuronide and 119.4 ± 42.9 ng/mL L-menthol, Figure 1). The peak of 
menthol glucuronide was reached 6 hours after SKINMENT (Figure 1, p<0.05), showing 
a concentration ~5.5 times higher than that of L-menthol (223.8 ± 157.0 ng/mL 
menthol glucuronide and 40.5 ± 10.0 ng/mL L-menthol). However, even at its peak, 
menthol glucuronide concentration in SKINMENT was significantly lower than in 
ORALMENT (Figure 1, p<0.05). 
 
Thermogenesis and metabolic response 
Regarding our first hypothesis, figure 2 shows that SkBF was reduced (p<0.05) 
within 1 hour following both ORALMENT (66.5% reduction) and ORALCON (79.5% 
reduction); the latter reduction being significantly greater (p<0.05).  
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Figure 2: Results (mean ± SEM) and comparisons for skin blood flow [SkBF in perfusion 
units (PU)], mean skin temperature (Tsk), and rectal temperature (Tre) at baseline (Base) and 
for 7 hours after oral and skin treatments. Note: * = significant differences from baseline within 
the same treatment (Wilcoxon Signed-Rank tests, p<0.05); ǂ = significant differences from 
the previous time-point within the same treatment (Wilcoxon Signed-Rank tests, p<0.05); † = 
significant differences between control and L-menthol treatments within the same group for 
the same time-point (Wilcoxon Signed-Rank tests, p<0.05); Ṩ = significant differences 
between SKIN vs. ORAL group for the same treatment and time-point (Mann-Whitney U tests, 
p<0.05). 
   
The changes observed in Tsk and Tre were similar in ORALMENT and ORALCON (Figure 
2, p>0.05). Indeed, after treatments Tsk was attenuated by 1% within 1 hour (p<0.05) 
while Tre was increased by 0.1% within 3 hours (p<0.05). 
SkBF was reduced within 15 min (at time 0) following only SKINMENT (55% 
reduction; Figure 2, p<0.05). Within 1 hour from the treatment, SkBF was reduced in 
both SKINMENT (75% reduction) and SKINCON (49% reduction); the former reduction 
being significantly greater (Figure 2, p<0.05). The changes observed in Tsk and Tre 
were more evident in SKINMENT compared to SKINCON (Figure 2, p<0.05). Specifically, 
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in SKINMENT, Tsk was attenuated by 1.1% within 1 hour and by 1.4% within 2 hours 
(p<0.05) after treatment, while Tre was increased by 0.2% within 1 hour and by 0.3% 
within 2 hours (p<0.05) after treatment. In contrast, in SKINCON, Tsk was attenuated by 
only 0.8% within 1 hour and by 1.2% within 2 hours (p<0.05) after treatment, while Tre 
was decreased by 0.1% within 1 hour (p<0.05) after treatment (Figure 2). 
Mann-Whitney U tests indicated that S, M, and RER were significantly 
different between groups for the same treatment (i.e., ORALMENT vs. SKINMENT and 
ORALCON vs. SKINCON; Figure 3, p<0.05), while Wilcoxon Signed-Rank tests showed 
that significant differences between treatments within the same group (i.e., ORALCON 
vs. ORALMENT and SKINCON vs. SKINMENT) were observed only in RER (Figure 3, 
p<0.05). Specifically, during the first 5 hours from the treatment, the increase 
observed in S during ORALMENT was similar to that observed in ORALCON (Figure 3, 
p<0.05); the former increase being slightly lower (p>0.05).  
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Figure 3: Results (mean ± SEM) and comparisons for heat storage (S), metabolic rate (M) 
and respiratory exchange ratio (RER) at baseline (Base) and for 7 hours after oral and skin 
treatments. Note: * = significant differences from baseline within the same treatment 
(Wilcoxon Signed-Rank tests; p<0.05); ǂ = significant differences from the previous time-point 
within the same treatment (Wilcoxon Signed-Rank tests; p<0.05); † = significant differences 
between control and L-menthol treatments within the same group for the same time-point 
(Wilcoxon Signed-Rank tests; p<0.05); Ṩ = significant differences between SKIN vs. ORAL 
group for the same treatment and time-point (Mann-Whitney U tests; p<0.05).   
 
Nevertheless, within 6 hours from the treatment, the increase observed in S was 
more pronounced during ORALMENT (1000%) compared to ORALCON (136%) (Figure 
3, p<0.05). By 7 hours from the treatment, S increased by 943% (p<0.05) during the 
ORALMENT and by only 83% (p<0.05) during the ORALCON. The changes observed in 
M during the ORALMENT and the ORALCON were opposite in trend (Figure 3, p<0.05). 
Specifically, in ORALMENT, M was attenuated by 12% (p<0.05) within 1 hour from the 
treatment and it subsequently demonstrated an upward trend reaching an increase of 
10% within 6 hours from the treatment (Figure 3, p<0.05). In contrast, in ORALCON, M 
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was significantly increased by 7% (p<0.05) within 1 hour from the treatment and it 
was subsequently attenuated reaching baseline levels within 2 hours from the 
treatment (Figure 3, p>0.05). The RER was reduced within 1 hour after the treatment 
in both ORALMENT (5.4% reduction; p<0.05) and ORALCON (2.3% reduction, p<0.05); 
the former reduction being significantly greater (Figure 3, p<0.05). 
Statistically significant increases in S and M were observed in SKINMENT and 
SKINCON; the former increase being significantly greater (Figure 3, p<0.05). 
Specifically, within 2 hours from the treatment, S was increased by 522% (p<0.05) in 
SKINMENT and by only 110% (p<0.05) in SKINCON, while M was increased by 11% 
(p<0.05) in SKINMENT and by only 3% (p<0.05) in SKINCON. Within 7 hours from the 
treatment, S was increased by 700% (p<0.05) in SKINMENT and by only 160% 
(p<0.05) in SKINCON, while M was increased by 18% (p<0.05) in SKINMENT and by only 
6.7% (p<0.05) in SKINCON. Within 1 hour after the treatment, the RER was reduced in 
both SKINMENT (4.8% reduction, p<0.05) and SKINCON (7% reduction, p<0.05); the 
latter reduction being significantly greater (Figure 3, p<0.05). 
 
Plasma hormones concentration 
Mann-Whitney U tests showed that leptin (p<0.05) but not adiponectin or 
leptin/adiponectin ratio (p>0.05), was significantly different between groups for the 
same treatment. ORALMENT
 (5.5 ± 1.2 ng/mL at baseline vs. 3.6 ± 0.5 ng/mL at 1-
hour) and ORALCON (4.5 ± 0.7 ng/mL at baseline vs. 2.7 ± 0.3 ng/mL at 1-hour) 
resulted in a significant decrease of leptin within 1 hour (p<0.05), while SKINMENT (2.9 
± 1.27 ng/mL at baseline vs. 1 ± 0.3 ng/mL at 6-hours) and SKINCON (1.4 ± 0.4 ng/mL 
at baseline vs. 1 ± 0.3 ng/mL at 6-hours) demonstrated significant reductions in leptin 
within 6 hours (p<0.05). 
 
Autonomic modulation 
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Results from Mann-Whitney U and Wilcoxon Signed-Rank  tests indicated that the 
analysed HRV indices from the frequency, time and nonlinear domains were not 
significant different between groups for the same treatment and between treatments 
within the same group, showing a similar trend in ORALMENT, ORALCON, SKINMENT and 
SKINCON without any significant variation throughout the entire assessment period 
(p>0.05). 
 
Thermal comfort and sensation response 
Mann-Whitney U test indicated that responses in thermal comfort and sensation were 
significant different between groups for the same treatment (i.e., ORALMENT vs. 
SKINMENT and ORALCON vs. SKINCON) (Figure 4, p<0.05).  
 
Figure 4: Results (mean ± SEM) and comparisons for thermal comfort and sensation at 
baseline (Base) and for 7 hours after oral and skin treatments. Note: * = significant 
differences from baseline within the same treatment (Wilcoxon Signed-Rank tests; p<0.05); ǂ 
= significant differences from the previous time-point within the same treatment (Wilcoxon 
Signed-Rank tests; p<0.05); † = significant differences between control and L-menthol 
treatments within the same group for the same time-point (Wilcoxon Signed-Rank tests; 
p<0.05); Ṩ = significant differences between SKIN vs. ORAL group for the same treatment 
and time-point (Mann-Whitney U tests; p<0.05). 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 08:36:14 EEST - 137.108.70.13
65 
 
Thermal comfort response showed significant differences between ORALMENT and 
ORALCON (Figure 4, p<0.05). Indeed, within 3 hours from the treatment, the 
participants in ORALMENT reported being more uncomfortable than in ORALCON 
(Figure 4, p<0.05). On the other hand, thermal sensation response showed no 
significant difference between ORALMENT and ORALCON (Figure 4, p>0.05).  
Thermal comfort response showed no significant difference between 
SKINMENT and SKINCON (Figure 4, p>0.05). However, immediately after the treatment 
(at time 0, p<0.05) participants in SKINMENT reported being more uncomfortable than 
during SKINCON (Figure 4, p<0.05). Within 4 hours following treatment in SKINMENT 
the thermal comfort response returned to baseline (i.e., “comfortable”; Figure 4, 
p>0.05). Thermal sensation response showed significant difference between 
SKINMENT and SKINCON (Figure 4, p<0.05). Specifically, within 1 hour after the 
treatment (p<0.05), participants in SKINMENT reported being cooler than in SKINCON 
(Figure 4, p<0.05). 
All participants reported no stress, discomfort or shivering during the entire 
assessment period. Moreover, participants in SKINMENT perceived no skin irritation 




This is the first study aiming to assess and compare the absorption and metabolism 
pharmacokinetics of a single L-menthol oral versus skin administration and 
investigate their effects on thermogenesis and metabolic rate in men and women. We 
found that a single skin L-menthol administration can increase thermogenesis and 
metabolic rate in humans while these effects are minor following a single oral L-
menthol administration. 
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Our novel findings show that the administration of L-menthol through the skin 
(i.e., gel) leads to very low absorption in the body. Indeed, the total L-menthol 
following SKINMENT represented 6% of that observed following ORALMENT. 
Nevertheless, when administered through the skin, the metabolism of L-menthol was 
very slow, as indicated by the low menthol glucuronide concentration within 1 and 6 
hours following administration. This slow metabolism of L-menthol when 
administered through the skin may explain the reduced heat loss (as seen through 
attenuated skin blood flow and mean skin temperature) and augmented 
thermogenesis (as seen through metabolic rate) which, in turn, lead to increased 
body heat storage and rectal temperature. Moreover, L-menthol administration 
through the skin (i.e., gel), but not through the gastrointestinal tract (i.e., capsule), 
results in a greater RER – corresponding to an increased carbohydrate oxidation 
compared to the control condition – within 1 hour. 
Administration of L-menthol through the gastrointestinal tract leads to a very 
high absorption in the body. Indeed, the total L-menthol observed following 
ORALMENT was ~16 times higher than that observed following SKINMENT. 
Nevertheless, when administered through the gastrointestinal tract, the metabolism 
of L-menthol was very fast, as indicated by higher menthol glucuronide concentration 
within 1 and 2 hours following oral administration compared to the skin. L-menthol 
levels following oral administration were similar to that following skin administration, 
therefore the very high menthol glucuronide concentration observed when L-menthol 
was administered through the gastrointestinal tract may explain the minor effects 
observed in heat loss attenuation and thermogenesis following administration. Our 
findings on the high metabolism of L-menthol when administered through the 
gastrointestinal tract are in line with previous studies (Gelal et al. 1999; Hiki et al. 
2011) reporting that L-menthol gastrointestinal absorption results in low (or 
undetectable) levels of L-menthol and high levels of menthol glucuronide in the 
blood. Interestingly, we found that the peak of menthol glucuronide concentration in 
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the blood (1-2 hours after the L-menthol capsule ingestion) corresponded to a strong 
reduction in metabolic rate compared to the control condition and L-menthol gel 
application, suggesting an inhibitory effect on metabolism by the menthol glucuronide 
and/or glucuronidation process. Altogether these results suggest that L-menthol 
concentration in the blood should be high enough, without the interference of its 
glucuronide form, to activate an unknown mechanism which augments carbohydrate 
oxidation and thermogenesis. 
The overall increase in energy expenditure – as measured by the gain in 
metabolic rate – after the L-menthol gel application is in accordance with the results 
of a previous in vitro study which reported that L-menthol induces an increase in 
glucose uptake and heat production in human white adipocytes (Rossato et al. 2014). 
Moreover, in accordance with previous studies, our analysis shows that a single 
application of L-menthol gel resulted in a significant decrease in skin blood flow 
(Yosipovitch et al. 1996; Olive et al. 2010; Topp et al. 2011; Gillis et al. 2015) and 
mean skin temperature (Yosipovitch et al. 1996; Olive et al. 2010; Topp et al. 2011) 
as well as in a significant increase in rectal temperature (Gillis et al. 2015). In 
contrast to our results, the latter study reported no effects of a single L-menthol skin 
spray solution on mean skin temperature and mean body temperature (Gillis et al. 
2015). This may be explained by the lower L-menthol concentration (about 1/3 of that 
used in our experiment) as well as the thermometrically-derived calculation of mean 
body temperature used in the study by Gillis et al. (2015). 
Our data indicate that L-menthol capsule ingestion caused a decrease in skin 
blood flow and mean skin temperature, unlike a previous study which reported no 
such effects after the ingestion of 10 mg L-menthol (Gelal et al. 1999). These 
contradictory results may be explained by the difference in L-menthol dosage. For 
instance, in the previous oral administration study, the lower L-menthol dose 
administrated (which resulted in undetectable blood L-menthol levels due to its rapid 
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conversion in the glucuronide form) could have suppressed the effect on skin blood 
flow and mean skin temperature (Gelal et al. 1999).  
Since BAT activation was not assessed in the present analysis, the observed 
L-menthol gel application effect in increasing human thermogenesis and metabolic 
rate could not be certainly attributed to the activation of UCP1 mediated by blood L-
menthol as reported in previous animal studies (Tajino et al. 2007; Ma et al. 2012). In 
our study, participants rested and fasted for the entire assessment period in a 
thermoneutral environment. Thus, considering the absence of physical activity, diet-
induced thermogenesis or shivering, it seems reasonable to suggest that the gain in 
thermogenesis after L-menthol gel application, may be mediated by non-shivering 
thermogenesis. Specifically, our results suggest that the increase in body heat 
storage observed within the first 2 hours after skin L-menthol administration resulted 
from both the increase in metabolic rate and attenuation in cutaneous 
vasoconstriction which is due to mainly for the resting and fasting condition in a 
thermoneutral environment, as similar results were also observed after the control 
conditions. Thereafter, the further increase in body heat storage was primarily due to 
an increase in metabolic rate since no further reduction in cutaneous vasoconstriction 
was observed. Nevertheless, further analysis should clarify the involvement of BAT 
activity in increasing body temperature and metabolism in humans after a single L-
menthol gel application as well as evaluate if a daily application may lead to a 
reduction of body weight and adiposity levels in humans. Moreover, as the capsule 
ingestion resulted in a very high L-menthol absorption but the increased menthol 
glucuronide interfered with the effects of L-menthol on metabolism activation, it would 
be interesting to use an inhibitory mechanism for the conversion of L-menthol in its 
glucuronide form and then evaluate the efficacy of ingestible L-menthol on 
thermogenesis and metabolism. 
An animal study reported that daily oral L-menthol administration in mice 
increases insulin sensitivity (Ma et al. 2012). Moreover, human studies reported that 
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there is high correlation between insulin sensitivity and leptin/adiponectin ratio in both 
adults and children with a lower leptin/adiponectin ratio corresponding to higher 
insulin sensitivity (Hung et al. 2006; Finucane et al. 2009; Oberhauser et al. 2012). 
The present study showed that a single L-menthol oral or skin administration does 
not have effect on the levels of leptin, adiponectin or leptin/adiponectin ratio in the 
blood. Indeed, the decrease of leptin after either L-menthol gel or capsule 
administration was probably caused by the fasting condition during the entire 
assessment period which, in turns, resulted in the increase of participants’ hunger, as 
similar results were also observed after the control conditions. In this light, it is worth 
mentioning that the prolonged fasting could have interfered in part with the L-menthol 
administration and therefore, besides explaining some of the observed results (i.e., 
decrease of leptin), may have masked part of L-menthol effects. Thus, further studies 
should analyse a long term effect after daily L-menthol gel and capsule 
administration on insulin and carbohydrate metabolism in humans. 
Menthol products have shown different healthy physiological effects. They 
have been successfully used for many decades as a natural analgesic gel for pain 
(Fang et al. 2008) and as an oral treatment for disinfection (Iscan et al. 2002). Both 
oral and skin L-menthol administration were very well tolerated by the participants as 
thermal comfort and sensation ranged from “comfortable” to “slightly uncomfortable” 
and from “neutral” to “slightly cool”, respectively. Moreover, participants reported no 
discomfort, shivering, skin irritation, or stress (which was evident also from the 
unchanged HRV indices) throughout the assessment period. A previous study 
reported that half of the participants sprayed with an L-menthol solution perceived 
skin irritation, indicating that a cream solution may be more appropriate as well as 
that there may be large inter-individual variation in the perception of irritation after a 
single skin L-menthol application (Gillis et al. 2015). The current results showed no 
apparent detrimental cardiovascular effects (as evidenced by stable heart rate 
variability recordings) after a single dose of 10 mg·kg-1 body weight of L-menthol 
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which, in contrast, are evident following specific drugs that also boost metabolic rate 
(Cypess et al. 2012; Vosselman et al. 2012; Carey et al. 2013; Cypess et al. 2015). 
Finally, it is important to note that very small differences at baseline between 
treatments which were deemed as statistically significant by our statistical analysis 
(e.g., a 0.1°C difference in Tre between ORALMENT and ORALCON) are of no 
physiological significance as they are within the normal day-to-day variation. 
Therefore, these differences are not considered in the context of this study’s findings. 
On the other hand, consistent differences in rectal temperature as high as 0.23 °C 
within 2 hours that cannot be explained by factors other than L-menthol treatment are 
of major physiological significance. 
In conclusion, we show that a single administration of L-menthol via a gel 
cream increased thermogenesis and metabolic rate in humans. These effects are 
minor following oral L-menthol administration probably due to a faster metabolism of 
L-menthol (i.e., glucuronidation process) that occurs when the molecule is absorbed 
through the gastrointestinal tract leading to higher menthol glucuronide concentration 
following the oral administration compared to the skin. Considering the tolerability of 
a single L-menthol administration, future chronic studies are necessary to confirm L-
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We analysed, for the first time, the effect and dose-dependent effect, of 1-month daily 
L-menthol cream administration on metabolism, body composition, and white adipose 
tissue plasticity in humans. Twenty-one healthy volunteers (33.8 ± 6.3 years, 26.1 ± 
3.5 kg·m2 body mass index, 23.4 ± 8.9 body fat percentage) were randomly placed 
in the control (0 mg·kg-1 body weight of L-menthol crystals), low L-menthol 
concentration (10 mg·kg-1 body weight of L-menthol crystals) or high L-menthol 
concentration (20 mg·kg-1 body weight of L-menthol crystals) group and they were 
asked to apply on the skin surface of their legs, arms, neck, chest and belly, the L-
menthol or control creams once a day for 30 days. Physical activity, dietary nutrient 
intake, thermal comfort and sensation were recorded three days/week while analysis 
of resting metabolic rate, heart rate variability, and body composition, as well as 
abdominal skin and subcutaneous adipocytes biopsies were performed at baseline 
and one day after the last application. Daily application of either lower or higher L-
menthol creams showed no effect on body composition, metabolism and white 
adipose tissue plasticity. The increase of adiponectin in white adipocytes could 
indicate that a process for increasing metabolism may have started with no changes 
in body composition and metabolism maybe due to the short period. Further analysis 
on protein expression and activity of factors involved in metabolism and white 
adipose tissue plasticity as well as on human cold-sensitive gating receptors are 
essential to clarify the effect of L-menthol on human metabolism and thermogenesis. 
 
KEYWORDS: brown adipose tissue; brite adipocytes; non-shivering thermogenesis; 
obesity; TRPM8; TRPA1; sodium intake. 
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White, brown and brown-like (“brite”) cells represent the three different kinds of 
adipocytes in mammals. White adipocytes play a role in storing energy while brown 
and brite adipocytes are involved in heat production, showing metabolic capabilities 
and potential for increasing energy expenditure through the activation of a 
mitochondrial inner membrane protein, uncoupling protein 1 (UCP1) (Inokuma et al. 
2006; Feldmann et al. 2009; Mattson 2010; Valente et al. 2014). A systematic 
analysis from our group suggests that frequent stimulation of UCP1 in mammal 
brown and brite adipocytes results in an increase of basal metabolic rate and a 
reduction of adiposity levels in rodents (Inokuma et al. 2006; Yamashita et al. 2008; 
Feldmann et al. 2009; Yoneshiro et al. 2013; Valente et al. 2014). Animal studies 
identified L-menthol as an activator of UCP1 in rodent brown adipocytes through the 
stimulation of the transient receptor potential melastatin 8 ion channel (TRPM8) 
which is the principal sensor of thermal stimuli in the peripheral nervous system 
(Romanovsky 2007; Tajino et al. 2007; Flouris 2011; Tajino et al. 2011; Ma et al. 
2012; Valente et al. 2014). TRPM8 is predominantly located on the cell membrane of 
sensory neurons while its expression has also been recently discovered on the 
membrane of brown and white adipocytes (Wang and Woolf 2005; Bautista et al. 
2007; Colburn et al. 2007; Dhaka et al. 2007; Tajino et al. 2011; Ma et al. 2012; 
Rossato et al. 2014). It seems that alternative mRNA splicing of this receptor is an 
important regulatory process for its activity as shorter isoforms (TRPM8α and 
TRPM8β, reported here as TRPM8-S) of the full-length TRPM8 (reported here as 
TRPM8-L) are translated in a non-functional ion channel receptor (Bidaux et al. 2012; 
Fernandez et al. 2012). 
Animal studies report that a single L-menthol skin application on the whole 
trunk in mice induces heat production and a rise in core temperature through skin 
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vasoconstriction, muscle shivering, and UCP1 activity in brown adipocytes (Tajino et 
al. 2007). Moreover, a 7-month dietary L-menthol administration in mice increases 
core temperature, UCP1 expression and activity in BAT, and insulin sensitivity 
leading to attenuated body weight gain (Ma et al. 2012). 
Our recent work indicates that a single administration of L-menthol via a gel 
cream increased thermogenesis and metabolic rate in humans maybe through UCP1 
activation (Valente et al. 2015). However, these effects are minor following oral L-
menthol administration probably due to a faster metabolism of L-menthol (i.e., 
glucuronidation process) that occurs when the molecule is absorbed through the 
gastrointestinal tract leading to higher menthol glucuronide concentration following 
the oral administration compared to the skin (Hiki et al. 2011; Valente et al. 2015). 
Moreover, an in vitro study on human white adipocytes reported that L-menthol 
induces UCP1 expression and activation in white adipose tissue, and increases 
glucose uptake and heat production (Rossato et al. 2014). Altogether, these findings 
suggest a possible role for L-menthol in controlling energy metabolism and energy 
balance in humans, although, chronic studies are necessary to confirm L-menthol as 
promising candidate treatment for human metabolic diseases.  
The purpose of the present work is to analyse, for the first time, the effect of 
1-month daily L-menthol cream administration on metabolism, body composition, and 
white adipose tissue plasticity in humans. We also tested the eventual L-menthol 
dose-dependent effect using lower and higher L-menthol concentration creams. 
Based on the aforementioned results of L-menthol effects in boosting human and 
rodent metabolism (Tajino et al. 2007; Ma et al. 2012; Valente et al. 2014; Valente et 
al. 2015), we hypothesized that 1-month daily L-menthol cream administration would 
increase human metabolism, decrease body weight and adiposity. Moreover, 
considering that L-menthol stimulates UCP1 in human white adipocytes (Rossato et 
al. 2014), we also hypothesized that daily L-menthol cream administration would 
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stimulate subcutaneous adipose tissue plasticity with UCP1 expression increased in 





The study conformed to the standards set by the Declaration of Helsinki and was 
approved by the University of Thessaly Department of Exercise Science Ethics 
Committee. A minimum required sample size of 6 participants per group was 
determined (statistical power: 0.95; α error probability: 0.05) based on body fat mass 
calculated before (11.7 ± 0.7 Kg) and after (10.9 ± 0.35 Kg) 6 weeks of cold exposure 
in a previous published study (Yoneshiro et al. 2013). Thus, 21 sedentary male 
healthy volunteers [33.8 ± 6.3 years, 26.1 ± 3.5 kg·m2 body mass index (BMI), 23.4 ± 
8.9 body fat percentage] were recruited for this study. Exclusion criteria included 
smoking, use of any medication, history or presence of metabolic, cardiac or 
pulmonary disease, thyroid or thermoregulatory disorders. Participants were informed 
about all experimental procedures, associated risks and discomforts and were asked 
to provide written informed consent.  
Volunteers were randomly placed into the control (0 mg·kg-1 body weight of L-
menthol crystals, CON), low L-menthol concentration (10 mg·kg-1 body weight of L-
menthol crystals, LM) or high L-menthol concentration (20 mg·kg-1 body weight of L-
menthol crystals, HM) group, each consisting of 7 participants. No differences in age 
(CON: 34.9 ± 8.4 years; LM: 33.9 ± 3.3 years; HM: 32.7 ± 6.9 years), body mass 
(CON: 79 ± 13.5 Kg; LM: 86.7 ± 13.7 Kg; HM: 85.1 ± 13.4 Kg), BMI (CON: 25.4 ± 4.7 
Kg∙m2; LM: 26.8 ± 2.9 Kg∙m2; HM: 26.1 ± 3.1 Kg∙m2), or body fat percentage (CON: 
22.6 ± 9.1 %; LM: 23.6 ± 8.1 %; HM: 23.9 ± 10.6 %), were detected among the tree 
groups (mean ± SD, p>0.05).  
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Cream preparation and research design 
Participants were asked to apply on the skin surface of their legs, arms, neck, chest 
and belly, the L-menthol or control creams once a day between 7:00 and 9:00 am for 
a total of 30 days. For an equal daily L-menthol distribution on the three areas of the 
body cream application (legs, arms, and neck-chest-belly), the total relative amount 
of L-menthol crystals (natural L-menthol FU-BP-USP; A.C.E.F. spa, Fiorenzuola 
d’Arda, Italy) was equally split and mixed in three cans cream containing each 10% 
of urea and 5 gr of base cream which composed by vaseline, olive oil, soy oil, 
avocado oil, macadamia oil, evening primrose oil and jojoba oil (A.C.E.F. spa, 
Fiorenzuola d’Arda, Italy). Control creams were composed by the base cream to 
which was added only 10% of urea. Thus, all participants received one little container 
of cream per day for legs, arms, and neck-chest-belly respectively, for a total of 
ninety containers cream which were kept in the refrigerator at 6-7 °C until use.  
Due to the strong smell of menthol, a double-blind design was adopted only in 
terms of L-menthol crystals concentration used to prepare the cream. All participants 
(including those in CON) as well as the researchers who performed dietary nutrient 
intake analysis, abdominal skin and subcutaneous adipose tissue biopsies, and gene 
expression analysis (described in the following paragraphs) were not informed about 
the L-menthol crystals concentration contained in the cream of each group (i.e., 0, 
low or high concentration). 
 
Experimental procedures  
The experimental protocol consisted of 1 week of baseline (from day -7 to day -1) 
following by 4 weeks of daily cream application (from day 0 to day 29) during which, 
all participants were asked to maintain their physical activity and dietary nutrient 
intake (food and beverage) as before the experimental period. During both baseline 
and each week of the cream application period, physical activity and dietary nutrient 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 08:36:14 EEST - 137.108.70.13
78 
 
intake were assessed using a pedometer (Digi-Walker SW–200, Yamax, United 
Kingdom) and a 24h diet recall interview, respectively, to eliminate the eventual 
impact on changes in metabolism and body composition. Participants were instructed 
to wear the pedometer on the right hip-pants, use it every day during the entire 
experimental period (baseline week and following 4 weeks of cream application) and 
remove it only for sleep and shower. To minimize the potential for changes in 
physical activity or eating, participants were blinded to the telephone recall schedule 
which was set for randomly three days/week (two week days and one weekend day) 
for the all experimental period. 
  Measurements were performed on both day -4 (baseline week) and day 30 
(one day after the last cream application) and participants were asked to abstain from 
alcohol, caffeine, and environmental tobacco smoke, to avoid any physical or mental 
stress and extreme temperature environments for 24-hour prior to each 
measurement day. Both measurement days all participants were transported to the 
laboratory via car to avoid excessive stressors between wake-up time and arrival at 
the laboratory.  They reported to the laboratory (which was maintained at 23.1 ± 0.9 
°C and 35.8 ± 3.4 % relative humidity) 30 min after waking (between 06:00 h and 
07:30 h) and after 12-hour overnight fast. Then, measurements of resting metabolic 
rate, HRV, body mass, height, body mass index, body fat percentage as well as 
subcutaneous adipose tissue biopsies (described in the following paragraphs) were 
performed at the same hour of the day and by the same trained researchers using 
identical pre-calibrated equipment.  
 
Dietary nutrient intake analysis 
All recorded food and beverages consumption were analyzed by one trained 
investigator using Nutritionist Pro, Version 5.4.0, Axxya Systems (Redmond, WA, 
USA). This software (i.e. Nutritionist Pro) has been previously used for research 
purposes (Michaliszyn et al. 2009; Stuempfle et al. 2013). For the analysis, a search 
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was conducted in Nutritionist Pro for each food and beverage consumed. Details 
regarding the amount and preparation of each food and/or beverage were also 
included. Once all the relevant information regarding the food or beverage was 
entered into the software, a corresponding list of macro and micronutrient content 
was provided and subsequently saved. This process was repeated for all food and 
beverages listed on the diet record. If a particular food or beverage was not found 
within the Nutritionist Pro database, the investigator manually entered the macro and 
micronutrient content of that particular food and saved it to the database for future 
use. The feedback provided by the software for each food or beverage included the 
following dietary variables: weight (g), kilocalories (kcal), protein (g), carbohydrate 
(g), total fat (g), alcohol (g), cholesterol (mg), saturated fat (g), monounsaturated fat 
(g), polyunsaturated fat (g), oleic acid (g), linoleic acid (g), linolenic acid (g), 
eicosapentaenoic acid (g), docosahexaenoic acid (g), trans fatty acid (g), sodium 
(mg), potassium (mg), vitamin A (IU), beta-carotene (μg), alpha-carotene (μg), lutein 
(+ zeaxanthin) (μg), beta-cryptoxanthin (μg), lycopene (μg), vitamin C (mg), calcium 
(mg), iron (mg), vitamin D (IU), vitamin E (IU), alpha-tocopherol (mg), thiamin (mg), 
riboflavin (mg), niacin (mg), pyridoxine (mg), total folate (μg), folate (DFE) (μg), 
cobalamin (μg), biotin (μg), pantothenic acid (mg), vitamin K (μg), phosphorus (mg), 
iodine (μg), magnesium (mg), zinc (mg), copper (mg), manganese (mg), selenium 
(μg), fluoride (μg), chromium (mg), molybdenum (μg), total dietary fiber (g), soluble 
fiber (g), insoluble fiber (g), crude fiber (g), total sugar (g), glucose (g), galactose (g), 
fructose (g), sucrose (g), lactose (g), maltose (g), sugar alcohol (g), other 
carbohydrate (g), tryptophan (mg), threonine (mg), isoleucine (mg), leucine (mg), 
lysine (mg), methionine (mg), cysteine (mg), phenylalanine (mg), tyrosine (mg), 
valine (mg), arginine (mg), histidine (mg), alanine (mg), aspartic acid (mg), glutamic 
acid (mg), glycine (mg), proline (mg), serine (mg), moisture (g), ash (g), caffeine 
(mg). The data of three-day diet records were divided by 3 in order to obtain for each 
week average results for kilocalories and each nutrient expressed as daily intake. 
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Resting metabolic rate and body composition analyses 
Resting metabolic rate was assessed to determine the effect of daily L-menthol 
cream application on metabolism. All measurements were conducted with 
participants in the supine position on a comfortable medical bed inside a semi-
darkened, temperature-controlled room (23.1 ± 0.9 °C) with other distractions 
minimized. Participants were asked to refrain from sleeping and hyperventilating 
during the procedure. Breath-by-breath data were collected using an automated gas 
analyser (Vmax, CareFusion, USA) which was calibrated before each test using 
standard gases of known concentrations. Respiratory variables were recorded every 
20 seconds for a total of 30 minutes data collection. The first and the last 5 minutes 
were excluded from the 30 minutes data collection to ensure participants’ habituation 
and avoid over restless interference (Adriaens et al. 2003). Resting metabolic rate 
was expressed per 24-hour and calculated as the average value of the 20 minutes 
data collection.   
Body weight and body fat percentage were assessed to determine the effect 
of daily L-menthol cream administration on body composition. All measurements 
were performed using bioelectrical impendence method with a body composition 
device (Fresenius Medical Care AG & Co. KGaA D-61346 Bad Homburg, Germany). 
 
HRV analysis 
To assess autonomic modulation, participants were outfitted with a heart rate chest 
strap and HRV was measured through short-range telemetry at 1,000 Hz with a Polar 
RS800CX (Polar Electro, Kempele, Finland). The heart rate monitor signal was 
transferred to the Polar Precision Performance Software (release 3.00; Polar Electro 
Oy), and RR intervals (time intervals between consecutive R waves in the 
electrocardiogram) were analysed in order to assess the modulation of sympathetic 
and parasympathetic activities as previously described (Flouris and Cheung 2009). 
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Frequency domain, time domain and nonlinear method analysis was 
performed using HRV software version 1.1 (Finland; Biomedical Signal Analysis 
Group, Department of Applied Physics, University of Kuopio, Finland 2002) 
evaluating the RR interval time series automatically obtained from the raw signals 
(Rajendra Acharya et al. 2006). The frequency domain with the low frequency, high 
frequency, and low frequency to high frequency ratio variables were analysed to 
discriminate between sympathetic and parasympathetic contribution to HRV. For the 
time domain method, both statistical and geometric parameters were considered for 
the analysis of Mean RR, Mean HR, standard deviation of RR and heart rate, the 
square root of the mean of squared differences between successive intervals, the 
percentage of the differences of successive normal-to-normal intervals 50 ms 
normalized to all differences within the interval, the number of pairs of successive 
normal-to-normal that differ by more than 50 ms, the HRV triangular index, and the 
triangular interpolation of normal-to-normal interval histogram. Nonlinear method was 
used to analyse the standard deviation of fast and long term RR variability, mean line 
length, maximum line length, recurrence rate, determinism, Shannon Entropy, 
approximate entropy, sample entropy, Detrended Fluctuation Analysis α 1 and 2, and 
correlation dimension. 
 
Abdominal dermis and subcutaneous adipose tissue biopsies 
A non-diathermy method was used to obtained abdominal dermis and subcutaneous 
adipose tissue biopsies. Each participant was positioned on a surgical bed in a 
supine position. The spot of the incision was disinfected and a 10 ml of xylocaine 2%-
no adrenaline was injected in the region of the incision for local anaesthesia. An 
incision on the dermis and subcutaneous tissue until adipose tissue was revealed, 
was executed approximately 3-5 cm on the right (on day -4) and symmetrically on the 
left (on day 30) from the navel. The incision length was approximately 2-2.5 cm. 
Subsequently, 50 mg of dermis and 500 mg of subcutaneous adipose tissue were 
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removed with an operating scissors. All samples were immediately frozen in liquid 
nitrogen and then stored at -80° C. 
 
Gene expression analysis 
Gene expression of Ucp1, Ppar-γ, Rald, Plac8, and Npra in white adipocytes was 
assessed to determine the effect of daily L-menthol cream application on white 
adipose tissue plasticity (Gray et al. 2006; Feldmann et al. 2009; Jimenez-Preitner et 
al. 2011; Kiefer et al. 2012; Valente et al. 2014). Gene expression of Pgc1-α, Cox IV, 
Leptin, Adiponectin, Ppar-α, Pgk1, Fabp3, and Glut4 in white adipocytes was 
assessed to determine the effect on metabolism activation in white adipose tissue 
(Virtanen et al. 2009; Bostrom et al. 2012; Vaughan et al. 2014). Gene expression of 
Trpm8-L and Trpm8-S in dermis was assessed to determine the levels of the 
functional receptor that could be activated by L-menthol and also eventual body 
adaptation to the daily application (Bidaux et al. 2012). Thus, total RNA was 
extracted from abdominal dermis and adipose tissue biopsies using RNeasy Lipid 
Tissue mini kit (QIAGEN) and ReliaPrep RNA Tissue Miniprep Systems (PROMEGA) 
respectively and following the manufacturer’s protocol. First-strand cDNAs were 
synthetized from equal amounts of total RNA using random primers and M-MLV 
reverse trascriptase (Promega). Quantitative real time PCR was performed using 
Sybr Green fluorofore. The change in fluorescence at every cycle was monitored and 
a threshold cycle above background for each reaction was calculated. A melt curve 
analysis was performed following every run to ensure a single amplified product for 
every reaction. All reactions were carried duplicates for every sample. 18S rRNA or 
RPL0 genes were constantly expressed under all experimental conditions and was 
then used as a reference gene for normalization. 
 
Thermal comfort and sensation 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 08:36:14 EEST - 137.108.70.13
83 
 
During the 4-week cream application, participants were frequently asked to report 
any kind of stress, discomfort or skin irritation as well as they were randomly asked 3 
days/week to indicate a number for thermal comfort and thermal sensation for each 
body area of the cream application (arms, legs, and neck-chest-belly) using 
previously published scales (Gagge et al. 1969). The range of the thermal comfort 
scale was from 1 through 5, where 1 = “comfortable”, 2 = “slightly uncomfortable”, 3 = 
“uncomfortable”, 4 = “very uncomfortable”, 5 = “extremely uncomfortable”. The range 
of the thermal sensation scale was from 0 through 10, where 0 = “unbearably cold”, 1 
= “very cold”, 2 = “cold”, 3 = “cool”, 4 = “slightly cool”, 5 = “neutral”, 6 = “slightly 
warm”, 7 = “warm”, 8 = “hot”, 9 = “very hot”, 10 = “unbearably hot”.  
 
Statistical analysis 
All dependent variables showed a non-normal distribution therefore non-parametric 
tests were used throughout. Mann–Whitney U tests were used for the comparisons 
between groups (i.e., CON vs LM; CON vs HM; LM vs HM) at the same time 
measurements. Wilcoxon Signed-Rank tests were used to compare values between 
baseline and day 30 within the same group. Moreover, for week-recording variables 
(diet nutrient intake, number of steps, thermal comfort and sensation), Wilcoxon 
Signed-Rank tests were used for the comparisons within the same group between 
baseline and each following week, between consecutive weeks as well as between 
baseline and the average of 4-week treatment period. All analyses were conducted 
with SPSS Statistics (version 19; SPSS Inc., Chicago, IL, USA). The data are 




Physical activity and diet nutrient intake 
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At baseline, steps/day were similar between groups (Figure 1-A; p>0.05). During the 
4-week cream application, steps/day did not change from baseline in CON, LM, and 
HM (p>0.05), showing similar levels of physical activity between groups (Figure 1-A; 
p>0.05). However, during the last week of cream application (week 4), steps/day 
significantly increased from the baseline in LM (Figure 1-A; p<0.05). 
At baseline, the daily intake of kilocalories, total fat, protein, carbohydrate, 
maltose, sodium, vitamin D and E was similar between CON and LM (p>0.05) as well 
as between CON and HM (Figure 1 – B, C, D, E, F, H, I, L; p>0.05). During the 
baseline week, the daily intake of galactose was lower in LM compared to CON 
(Figure 1 – G; p<0.05); the daily intake of kilocalories, total fat and protein was lower 
in LM compared to HM (Figure 1 – B, C, D; p<0.05). During the cream application 
period (from week 1 to week 4), kilocalories and protein daily intake increased from 
baseline only in CON (Figure 1 – B and D; p<0.05), while maltose, galactose and 
sodium daily intake increased from baseline only in LM (Figure 1 – F, G, H; p<0.05). 
On the other hand, the daily intakes of vitamin D and E decreased from baseline only 
in LM during week 4 and week 2 and 4, respectively (Figure 1 – I, L; p<0.05). 
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Figure 1. Results (mean ± SD) of Steps number (A), Kilocalories (B), Total fat (C), Protein 
(D), Carbohydrate (E), Maltose (F), Galactose (G), Sodium (H), Vitamin D (I), and Vitamin E 
(L), at baseline and the following week 1, 2, 3, and 4 of the cream application period in CON 
(0 mg·kg
-1
 body weight of L-menthol crystals), LM (10 mg·kg
-1
 body weight of L-menthol 
crystals), and HM (20 mg·kg
-1
 body weight of L-menthol crystals) groups. Note: * = significant 
differences from baseline within the same group; ǂ = significant differences from the previous 
week within the same group; $ = significant differences versus CON for the same week; # = 
significant differences HM vs LM for the same week; ─── = average of cream application 
period (from week 1 to week 4). 
Moreover, kilocalories and vitamin D daily intake during the cream application period 
(average from week 1 to week 4) in LM was lower compared to those in HM and 
CON (Figure 1 – B, I; p<0.05) as well as protein and vitamin E daily intake in LM was 
lower compared to those in HM and CON, respectively (Figure 1 – D, L; p<0.05). 
The daily intake of all the other analysed nutrients was not significant different 
among groups at both baseline and day 30, showing any significant variation from 
baseline throughout the entire cream application period in CON, LM, or HM (from 
week 1 to week 4) (p>0.05). 
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Body composition, body weight and RMR  
Table 1 shows that at baseline, BW, BMI, body fat %, RER, but not REE (p<0.05), 
were similar between groups (p>0.05). REE was significantly higher in LM and HM 
compared to CON (p<0.05) showing, however, similar levels between LM and HL 
(p>0.05). BW, BMI, body fat %, REE, and RER were similar between baseline and 
day 30 in CON, LM, and HM (p>0.05), although RER in LM showed a light 
attenuation after 30 days of L-menthol cream application (p>0.05). Moreover, at day 
30, BW, BMI, body fat %, REE, and RER were similar among groups (p>0.05). 
Table 1. Daily L-menthol cream administration effects on body weight, body mass index, body 
fat percentage, resting metabolic rate, and respiratory exchange ratio.  
Variable 
CON LM HM 
Baseline day 30 Baseline day 30 Baseline day 30 
BW (kg) 79.0±13.5 79.1±13.7 86.7±13.7 86.5±14.5 85.1±13.4 85.3±13.9 
BMI (Kg·m
2
) 25.5±4.7 25.5±4.7 26.8±2.8 26.7±2.9 26.2±3.1 26.2±3.3 
Body fat (%) 22.6±9.1 22.5±9.0 23.6±8.1 23.7±7.3 24.0±10.6 23.1±10.9 





RER 0.81±0.07 0.83±0.07 0.81±0.04 0.78±0.09 0.78±0.05 0.80±0.09 
Note:); Ṩ = significant differences vs. CON group for the same time-point (Mann-Whitney U tests; p<0.05). 
Key: CON = control group (0 mg·kg
-1
 body weight of L-menthol crystals); LM = low L-menthol concentration group (10 
mg·kg-1 body weight of L-menthol crystals); HM = high L-menthol concentration group (20 mg·kg-1 body weight of L-




HRV indices from the frequency, time and nonlinear domains were not significant 
different among groups at both baseline and day 30, showing a similar trend in CON, 
LM, and HM without any significant variation from baseline throughout the entire 
experimental period (from week 1 to week 4) (p>0.05). 
 
Abdominal dermis and subcutaneous adipose tissue gene expression 
Figure 2 show that the expression of Trpm8-L at both baseline and day 30 is 
significantly lower than that of Trpm8-S in both LM and HM groups, with the long and 
short isoforms representing ~1% and ~ 99% of the Trpm8 expressed in dermis, 
respectively. However, in both LM and HM groups the expression of Trpm8-L and 
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Trpm8-S isoforms did not change from baseline following 30 days of L-menthol 
cream application. 
 
Figure 2: Results (mean ± SD) of dermis relative mRNA expression of TRPM8-L (full-length 
functional isoform) and TRPM8-S (short non-functional TRPM8α and TRPM8β isoforms) at 
baseline and the day after the last cream application (day 30) in LM (10 mg·kg
-1
 body weight 
of L-menthol crystals) and HM (20 mg·kg
-1
 body weight of L-menthol crystals) groups. Note: # 
= significant differences for TRPM8-S versus TRPM8-L within the same group for the same 
time-point. 
 
 Figure 3 show that the subcutaneous adipose tissue expression of Ucp1, 
Rald, Plac8, Npra, Pgc1-α, Cox IV, Ppar-γ, Leptin, Adiponectin, Ppar-α, Pgk1, 
Fabp3, Glut4, Trpm8-L at both baseline and day 30 was not different among CON, 
LM, and HM. Moreover, the expression level of all analysed genes was unchanged 
from baseline after 4 weeks of daily cream application in CON, LM, and HM, expect 
for Adiponectin in HM group. Indeed, Adiponectin increased following 4 weeks of 
daily L-menthol cream application only in HM group. Interestingly, the expression of 
Trpm8-S was not detectable in subcutaneous adipocytes, with TRPM8-L being the 
single isoform expressed in subcutaneous adipose tissue. 
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Figure 3: Results (mean ± SD) of white adipose tissue relative mRNA expression of UCP1, RALD, PLAC8, NPRA, PGC1α, COX IV, PPARγ, Leptin, 3 
Adiponectin, PPARα, PGK1, FABP3, Glut4, TRPM8-L, and TRPM8-S, at baseline and the day after the last cream application (day 30) in CON (0 mg·kg-1 4 
body weight of L-menthol crystals), LM (10 mg·kg
-1
 body weight of L-menthol crystals) and HM (20 mg·kg
-1
 body weight of L-menthol crystals) groups. Note: * 5 
= significant differences from baseline within the same group. 6 
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Thermal comfort and sensation response 
Thermal comfort response did not show significant differences among CON, HM, and 
LM (p>0.05) as well as among arms, legs or chest-belly body areas in each group 
(Figure 4, p>0.05). Indeed, participants in all groups reported being between slightly 
uncomfortable and uncomfortable throughout the entire cream application period 
(from week 1 to week 4) without any significant differences among arms, legs and 
chest-belly body areas   (p>0.05).   
 
Figure 4: Results (mean ± SD) of thermal comfort and sensation of arms, legs, and chest-
belly at week 1, 2, 3, and 4 of the cream application period in CON (0 mg·kg
-1
 body weight of 
L-menthol crystals), LM (10 mg·kg
-1
 body weight of L-menthol crystals), and HM (20 mg·kg
-1
 
body weight of L-menthol crystals) groups. Note: $ = significant differences versus CON for 
the same week. 
Thermal sensation response showed significant differences between CON 
and LM or HM for arms, legs and chest-belly body areas (Figure 4; p<0.05). Indeed, 
participants in CON reported being neutral while participants in both LM and HM 
reported similar sensation (p>0.05) between slightly cool and cold without any 
significant differences among arms, legs and chest-belly body areas (p>0.05). 
All participants reported no stress, discomfort or skin irritation during the 
entire cream application period and for at least 7 days past the last cream application 
day. 
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This is the first study aiming to assess the effect of 1-month daily L-menthol skin 
administration on metabolism, body composition and subcutaneous white adipose 
tissue plasticity in humans. Also, we assessed the eventual L-menthol dose-
dependent effect using lower (10 mg·kg-1 body weight of L-menthol crystals, LM) and 
higher (20 mg·kg-1 body weight of L-menthol crystals, HM) L-menthol concentration 
creams. We found that 1-month of daily application of either lower or higher L-
menthol creams did not have an effect on metabolism, body composition and white 
adipose tissue plasticity in humans. 
Our novel findings show that body weight, BMI, body fat percentage, resting 
metabolic rate and respiratory exchanged ratio did not change following 1-month of 
daily L-menthol cream application. Moreover, factors involved in the subcutaneous 
white adipose tissue plasticity (i.e, Ucp1, Ppar-γ, Rald, Plac8, Npra, and T3) as well 
as factors involved in metabolism activation (i.e, Pgc1-α, Cox IV, Leptin, Ppar-α, 
Pgk1, Fabp3, and Glut4) did not change their gene expression in subcutaneous white 
adipose tissue following 1-month of daily L-menthol cream application.  
At baseline, the dermis of participants in both LM and HM groups expressed 
higher levels of the short isoform of Trpm8 compared to the long isoform. On the 
other hand, subcutaneous white adipocytes of LM, HM, and control groups 
expressed only the full-length isoform of Trpm8, with undetectable levels of the short 
isoforms. The full-length isoform of Trpm8 which is the only one that can be 
translated in a functional ion channel, represented ~1% and 100% of the Trpm8 
expressed in dermis and subcutaneous adipose tissue, respectively. Thus, L-menthol 
cream applied on the skin may have stimulated only 1% of the TRPM8. A better 
stimulation of this receptor could have been achieved on the surface of white 
adipocytes after the absorption of L-menthol in the blood, although the following 
glucuronidation process seems to interfere with L-menthol-mediated TRPM8 
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activation (Valente et al. 2015). L-menthol cream application did not influence the 
alternative splicing of Trpm8 because the day after the last L-menthol cream 
application in LM and HM groups, both full-length and short isoform of Trpm8 did not 
change their expression levels in either dermis or white adipocytes. Therefore, the 
failure of daily L-menthol cream application in increasing metabolism and white 
adipose plasticity as well as decreasing adiposity may be attributed to the very low 
expression of the full-length isoform of Trpm8 in dermis at baseline rather than to a 
higher expression of the short TRPM8 isoforms. However, analysis on TRPM8 
protein levels is necessary for confirmation. An alternative reason could be the 
increase of skin glucuronidation due to the daily exposure of dermis to L-menthol 
leading to high menthol glucuronide levels in the body. However this alternative is 
unlikely because a previous study reported a limited contribution of the skin to the 
body's total phase II drug metabolism in humans (Manevski et al. 2015). Moreover, 
considering that a single L-menthol administration has beneficial effect in increasing 
metabolism and thermogenesis in both human in vivo and in vitro white adipocytes 
(Rossato et al. 2014; Valente et al. 2015), we can hypothesize that an eventual body 
adaptation to the daily L-menthol cream application through a pathway TRPM8-
indipendent may also explain the observed results.  
Adiponectin gene expression was the only factor that increased in 
subcutaneous white adipocytes following 1-month of daily application of the lower L-
menthol concentration cream. Adiponectin plays a role in modulating a number of 
metabolic processes, including glucose regulation and fatty acid oxidation (Fang and 
Sweeney 2006; Chiarugi and Fiaschi 2010; Lim et al. 2014), thus these results may 
indicate that a process for increasing human metabolism may have started. However, 
since the cream application lasted 1 month, it is possible that the action of 
adiponectin in increasing metabolism may have not been strong enough and durable 
to increase resting metabolic rate and decrease body weight and adiposity. 
Interestingly, the increase in adiponectin was significant only in white adipocytes of 
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LM group but not of HM group. In-vitro studies showed that L-menthol increased 
TRPM8 expression and activity in a dose-dependent manner in human white 
adipocytes (Rossato et al. 2014) and lymph node carcinoma of the prostate cells as 
well as Chinese hamster ovary and monkey fibroblast-like cells (Mahieu et al. 2007). 
Our novel findings showed that dermis expressed both functional and non-functional 
TRPM8 isoforms while subcutaneous white adipose tissue expressed only the 
functional isoform, indicating a major role for dermis in responding and adapting to 
different thermal stimuli. As literature does not report a dose-dependent effect of L-
menthol on dermis TRPM8, it is reasonable to presume that the daily application of 
higher L-menthol concentration cream on the skin would have resulted in a possible 
desensitization or would have inhibited protein transcription or activity of the dermis 
TRPM8 in HM group through a negative feedback regulation, as dermis of 
participants showed no changes in mRNA expression of both TRPM8 isoforms 
following the application period. Future studies on TRPM8 protein levels are required 
to clarify the eventual dose-dependent effect on dermis TRPM8 expression and/or 
activity. 
During the 4 weeks of cream application, all participants reported no changes 
in their nutrients and kilocalories intake as well as in their physical activity explaining 
the unchanged results observed in body composition and metabolism. Interestingly, 
participants in LM group increased their physical activity only in the last week (week 
4) of cream application compared to the baseline. This may explain in part the 
increase in adiponectin gene expression in white adipocytes of LM group as exercise 
increases blood adiponectin levels in humans (Kriketos et al. 2004; Saunders et al. 
2012). Moreover, participants in LM group reported an increment in sodium intake 
during the whole cream application period compared to the baseline. Although the 
sodium intake increased only by 1-fold, this may also explain in part the increase 
observed in adiponectin gene expression in subcutaneous white adipocytes since 
previous animal and human studies reported that an increment of 4- or 20-fold in 
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sodium intake leads to increased blood adiponectin through renin-angiotensin-
aldosterone system suppression (Lely et al. 2007; Kamari et al. 2010; Krikken et al. 
2012; Mallamaci et al. 2013). However, the effect of sodium intake on adiponectin is 
still controversial as a study on mice reported that sodium restriction diet increased 
mRNA expression of adiponectin in visceral adipose tissue (Baudrand et al. 2014). 
Also, other human studies reported that the shift from high to low sodium intake does 
not have an effect on blood adiponectin levels (Campbell et al. 2014; Zhu et al. 
2014). It is worth noting that a human study reported that high sodium diet increases 
adiponectin in normotensive salt-resistant but not in salt-sensitive subjects (Liu et al. 
2012). In the present study we did not test the sensitivity to sodium of our 
participants, therefore whether the effect of L-menthol cream application in increasing 
adiponectin would have been larger in LM group if the rise in sodium intake had been 
prevented is one of the questions raised by this study. Further analyses on renin-
angiotensin-aldosterone system suppression following L-menthol cream application 
are required to clarify the process that increases adiponectin in subcutaneous white 
adipocytes.   
Our study showed that Ucp1 did not increase in white adipocytes following 
daily L-menthol administration, although further analysis on protein levels are 
necessary to confirm the effect of L-menthol on white adipose tissue plasticity. In 
accordance with our results, previous studies showed that UCP1 expression levels in 
rodent and human white adipocytes did not change following daily oral L-menthol 
administration and 10 days of cold exposure, respectively (Ma et al. 2012; van der 
Lans et al. 2013). Our human studies showed a significant but slight increase in 
metabolism and thermogenesis following a single L-menthol cream administration 
(Valente et al. 2015) and no effect on resting metabolic rate, body weight, and 
adiposity following 1-month of daily L-menthol cream application. In accordance with 
these results, human body weight did not change after chronic cold exposure of 
6h/day at 15-16 °C for a total of 10 days or 2h/day at 17 °C for a total of 6 weeks, 
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while fat mass decreased following the 6 weeks but not the 10 days, of cold exposure 
(van der Lans et al. 2013; Yoneshiro et al. 2013). In contrast to our results, animal 
studies reported that skin or oral L-menthol administration increased metabolism and 
non-shivering thermogenesis activation in rodents with higher levels of UCP1 in 
brown adipocytes as well as a great reduction in body weight gain and adiposity 
following daily oral L-menthol administration (Tajino et al. 2007; Ma et al. 2012). 
These controversial results between humans and rodents could be explained by 
divergence in thermal sensitivity that may be a result of adaptive evolution. Our 
results showed that, despite changes in season temperatures, dermis of all 
participants showed a higher expression of the non-active isoform of TRPM8 
compared to the active isoform, thus similar analysis in rodents may reveal an 
eventual divergence in thermal sensitivity. Moreover, a recent work reported that L-
menthol activates rodents but not primate transient receptor potential cation channel, 
subfamily A, member 1 (TRPA1) due to a variation of a single residue – G878 in 
rodents but V875 in primate – within S5 transmembrane domain of the receptor, with 
the residue G878 being determinant for species-specific L-menthol responses (Chen 
et al. 2013). This suggests that as in rodents L-menthol may stimulate both TRPA1 
and TRPM8, in humans may stimulate only TRPM8, explaining the controversial 
effect of L-menthol on human metabolism and thermogenesis activation (Karashima 
et al. 2007; Tajino et al. 2007; Tajino et al. 2011; Ma et al. 2012; Rossato et al. 2014; 
Valente et al. 2015). Interestingly, the protein sequences alignment in BLAST 
between mouse and human showed that 222 residues are different for TRPA1 and 
69 residues are different for TRPM8. Considering the identification of a single residue 
critical for L-menthol TRPA1 activation, it is reasonable to presume that L-menthol-
mediated TRPM8 activation in humans may be to a much less degree compared to 
that in rodents due to residues variation, which could represent an alternative or even 
further explanation of the observed results. Thus, molecular determinants analysis of 
cold-sensitive gating between TRPM8 of different species may be relevant for a 
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deeper understanding of L-menthol-mediated TRPM8 stimulation of human 
metabolism and thermogenesis. 
There are a number of limitations to the present study, some of which like the 
missing analysis at protein levels of the factors involved in metabolism activation, 
white adipose tissue plasticity and TRPM8 activity, have previously been discussed. 
Our estimation of dietary nutrients intake was based on self-reported 24-hour diet 
records three days a week that may underestimate the usual nutrient intake. Body fat 
percentage was assessed using bioelectrical impendence method which is not as 
accurate as other methods like dual-energy X-ray absorptiometry (DEXA). The 
eventual and uncontrolled evaporation of the menthol cream could have affected 
blood menthol levels and thus the overall results.  Limitations due to the self-applied 
cream by the participants were minimized by calling each participant <4 times a week 
asking for confirmation of cream application, feelings about the cream, eventual skin 
irritation, thermal comfort and sensation. 
In conclusion, we showed that 1-month of daily L-menthol cream application 
did not increase metabolism or white adipose tissue plasticity and did not affect body 
composition. However, the increase of adiponectin in white adipocytes could indicate 
that a process for increasing human metabolism may have started. The short cream 
application period and/or divergence in thermal sensitivity between rodents and 
humans may have resulted in a weaker stimulation of human metabolism leading to 
unchanged results in body weight, body composition and resting metabolic rate 
following L-menthol cream application. Thus, further analysis on protein expression 
and activity of factors involved in metabolism, white adipose tissue plasticity as well 
as on molecular determinants of human TRPM8 cold-sensitive gating are essential to 
clarify the effect of L-menthol-mediated TRPM8 stimulation on human metabolism 
and thermogenesis. 
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The present PhD project aims to identify factors that increase human metabolism and 
treat adipose excess through UCP1 activation. By integrating the results of the 
evaluated animal and human studies, our systematic analysis identified L-menthol as 
one of the molecules that can activate rodent UCP1 in brown and brite adipocytes 
(Valente et al. 2014). Indeed, the activation of UCP1 by L-menthol-mediated TRPM8 
stimulation increases rodent metabolism with a decrease in adiposity following 
frequent UCP1 activation (Tajino et al. 2007; Tajino et al. 2011; Ma et al. 2012). 
Our results showed that a single administration of L-menthol via a gel cream 
increased thermogenesis and metabolic rate in humans (Valente et al. 2015). These 
effects were minor following oral L-menthol administration probably due to a faster 
metabolism of L-menthol (i.e., glucuronidation process) that occurs when the 
molecule is absorbed through the gastrointestinal tract leading to higher menthol 
glucuronide concentration following the oral administration compared to the skin (Hiki 
et al. 2011; Valente et al. 2015). Thus, the research hypothesis 1 is rejected while the 
research hypothesis 2 is accepted as skin L-menthol administration increased human 
metabolism and thermogenesis with minor effect following the oral administration. On 
the other hand, we found that 1-month of daily application of either lower or higher L-
menthol creams did not increase metabolism or white adipose tissue plasticity and 
did not affect body composition in humans rejecting, therefore, the research 
hypotheses 3, 4 and 5. 
These results may be attributed to different reasons. First, the very low 
expression of the full-length isoform of Trpm8 in dermis may have resulted in low 
levels of the functional receptor activated by L-menthol. Second, an increase in skin 
glucuronidation process due to daily L-menthol cream application may have resulted 
in higher menthol glucuronide levels in the body interfering with TRPM8 stimulation. 
Third, a body adaptation to the daily L-menthol cream application through a pathway 
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TRPM8-indipendent may also be considered to justify the observed results. Another 
important aspect to be considered is the activity of TRPA1 and TRPM8 in rodents 
and humans. Indeed, in rodents L-menthol can stimulate both TRPA1 and TRPM8, 
while in humans L-menthol can stimulate only TRPM8 but not TRPA1 due to a single 
residue variation in human TRPA1 sequence that makes this receptor non-functional 
(Chen et al. 2013). As human TRPM8 sequence presents 69 residues that are 
different from rodent TRPM8 and a single residue is critical for L-menthol TRPA1 
activation, it is reasonable to assume that L-menthol-mediated TRPM8 activation in 
humans may be to a much less degree compared to that in rodents, explaining the 
greater effect of L-menthol on rodent metabolism, thermogenesis and adiposity loss 
compared to our results in humans. 
Given the above, future analysis on protein expression and activity of factors 
involved in metabolism and white adipose tissue plasticity following daily L-menthol 
administration, on human TRPM8 cold-sensitive gating and the consideration of the 
body fat percentage rather than the body mass of participants for L-menthol 
concentration cream are essential to clarify the effect of L-menthol-mediated TRPM8 
stimulation on human metabolism and thermogenesis and to confirm together with a 
healthy nutrition and physical activity, L-menthol as promising candidate treatment for 
human cardio-metabolic diseases. 
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